Page last updated: 2024-11-07

estrone and Menopause

estrone has been researched along with Menopause in 578 studies

Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research Excerpts

ExcerptRelevanceReference
"One hundred and one postmenopausal patients with advanced breast cancer were enrolled in a randomized phase II clinical trial to investigate the clinical and hormonal response to aminoglutethimide administered at daily doses of 2 x 125 mg, 3 x 125 mg or 2 x 250 mg, with no addition of hydrocortisone."9.06Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E, 1989)
"4-Hydroxyandrostenedione (CGP32349; 4-OHA) is a clinically effective treatment for advanced postmenopausal breast cancer by both the parenteral and p."9.06Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. ( Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC, 1989)
"A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years."9.05Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982)
"The effect of the dose of aminoglutethimide on the suppression of oestrone, oestradiol and dehydroepiandrosterone sulphate (DHAS) levels was studied in 36 women with advanced postmenopausal breast cancer, all of whom received 20 mg hydrocortisone twice daily as replacement glucocorticoid."9.05Aminoglutethimide dose and hormone suppression in advanced breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1983)
"The endocrine effects of replacement doses of hydrocortisone in postmenopausal women with advanced breast cancer were compared with the same doses of hydrocortisone plus aminoglutethimide."9.05Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE, 1984)
"Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase."7.68Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991)
"Values were determined by means of a ligand binding assay using 17-FE (17-fluoresceinated estrone) in 53 breast cancer patients."7.68[Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology]. ( Alamy, H; Baltali, E; Bouih, A; el Gueddari, B; el Hafed, A; Kettani, F; Morchid, M; Souadka, A; Souadka, F; Wydadi, M, 1990)
"The activities of aromatase and estrone sulfatase which are important enzymes involved in the local production of estrogen in breast cancer tissue were measured to examine their availability in endocrine therapy and their clinical significance."7.67[Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue]. ( Utsumi, T, 1989)
"The possibility that medroxyprogesterone acetate (MPA) is clinically effective at least in part by its suppression of adrenal steroidogenesis and a resultant reduction of circulating oestrogen levels was investigated in 49 postmenopausal patients with advanced breast cancer."7.67The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. ( Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE, 1987)
"5 mg, twice a day) aminoglutethimide (AG), without hydrocortisone (HC), escalating at monthly intervals to a conventional dose of AG (500 mg twice a day) combined with HC, were studied in 33 postmenopausal breast cancer patients."7.67Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. ( D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R, 1985)
"The effects of aging as well as body weight on conversion of circulating Androstendione (A) to Estrone (E1) in 21 postmenopausal women of different ages and body weights have been studied."7.67[Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women]. ( Ortega, E; Osorio, C; Ruiz, E, 1988)
"Estrone and estradiol-17 beta concentration in breast cancer tissue are reported to be an order of magnitude higher than those of circulating plasma in breast cancer patients."7.67[Serum estrone sulfate levels in patients with breast cancer]. ( Honjyo, H; Oka, T; Okada, H; Yasumura, T, 1988)
"The conversion of 1 beta [3H] androstenedione to estrone in the presence of NADPH by breast cancer homogenates was assessed in tumors from 35 subjects together with estrogen and progesterone receptor concentration."7.67Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. ( Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N, 1987)
"Oestrone sulphate, the oestrogen in highest concentration in the plasma, may play a role in the induction and growth of breast cancers."7.67Oestrone sulphate, adipose tissue, and breast cancer. ( Hawkins, RA; Killen, E; Thomson, ML, 1985)
"Postmenopausal women with metastatic breast cancer were treated with trilostane, initially 240 mg daily increasing after 3 days to 480 mg daily and after a further three days to 960 mg daily."7.67Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone. ( Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM, 1985)
"Peripheral serum levels of cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulphate (DHA-S), oestradiol-17 beta and total oestrone were measured in 17 postmenopausal breast cancer patients and on age-matched healthy controls."7.66Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. ( Carlström, K; Sköldefors, H; Theve, NO; Wallgren, A; Wilking, N, 1982)
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause."7.66Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982)
"To study the relation between body weight and height and the plasma sex-hormone levels wer measured the plasma levels of oestrone (E1), oestradiol (E2) and androstenedione (A) in a group of healthy post-menopausal women with a wide range of body weight."7.66Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height. ( de Waard, F; Poortman, J; Thijssen, JH, 1981)
"The daily excretion of estrone, estradiol, and estriol was determined for 22 normal women and 35 women with primary breast cancer."7.66Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. ( Dao, TL; Lonergan, PA; Morreal, CE; Nemoto, T, 1979)
"To determine if delta 1-testololactone can inhibit the peripheral aromatization of androstenedione (delta), nine postmenopausal women with metastatic breast cancer were studied before and after 2 weeks of therapy with 250 mg of the drug, given every 6 h by mouth."7.66Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. ( Barone, RM; Judd, HL; Shamonki, IM; Siiteri, PK, 1979)
"The concentrations of estrone (E1), androstenedione (A), testosterone (T) and sex-hormone-binding globulin (SHBG) in the serum were determined in 122 postmenopausal women, unselected with respect to age and stage of disease and with a newly diagnosed breast cancer."7.66Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. ( Adami, HO; Johansson, ED; Vegelius, J; Victor, A, 1979)
"The purpose of this study was to ascertain if a relationship exists between the transfer constant of conversion of plasma androstenedione to estrone ([rho]AE1BU) and total body weight or excessive body weight in 50 postmenopausal women, of whom 25 had adenocarcinoma of the endometrium and 25 had no endometrial disease."7.66Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. ( Edman, CD; Hemsell, DL; MacDonald, PC; Porter, JC; Siiteri, PK, 1978)
"We have infused [6,7-3H]estrone or [6,7-3H]estradiol and [4-14C]estriol into seven women who had had breast cancer and into five normal postmenopausal women."7.66Estriol production rates and breast cancer. ( Longcope, C; Pratt, JH, 1978)
"Fifty-nine postmenopausal women with advanced breast cancer were treated with tamoxifen (antiestrogen), 20 mg orally twice a day for at least 2 months."7.65Tamoxifen (antiestrogen) therapy in advanced breast cancer. ( Kennedy, BJ; Kiang, DT, 1977)
" There was a significant monotonic dose-response relationship of estrone sulfate in raising HDL levels, lowering LDL levels, and raising the HDL/LDL ratio at all intervals measured."6.67Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels. ( Green, EM; Jennings, D; Katz-Karp, S; Lancaster, J; Notelovitz, M; Stoll, RW, 1990)
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone."6.36Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977)
"Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast."5.30Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998)
"There was no change in the size of the uterine leiomyomata."5.28Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. ( Baird, DT; Lumsden, MA; West, CP, 1989)
"Ketoconazole was poorly tolerated due to gastrointestinal toxicity."5.27High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. ( Cantwell, BM; Dowsett, M; Harris, AL, 1988)
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days."5.27Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986)
" The dosages of E3 employed appear to vary considerably, and the need was felt to establish the dosage on a scientific basis."5.26The significance of oestriol in the management of the post-menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1980)
"Estriol was administered for a six-month period as estrogen replacement therapy to 52 symptomatic postmenopausal women."5.26Estriol in the management of the menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1978)
"One hundred and one postmenopausal patients with advanced breast cancer were enrolled in a randomized phase II clinical trial to investigate the clinical and hormonal response to aminoglutethimide administered at daily doses of 2 x 125 mg, 3 x 125 mg or 2 x 250 mg, with no addition of hydrocortisone."5.06Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E, 1989)
"4-Hydroxyandrostenedione (CGP32349; 4-OHA) is a clinically effective treatment for advanced postmenopausal breast cancer by both the parenteral and p."5.06Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. ( Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC, 1989)
"A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years."5.05Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982)
"The effect of the dose of aminoglutethimide on the suppression of oestrone, oestradiol and dehydroepiandrosterone sulphate (DHAS) levels was studied in 36 women with advanced postmenopausal breast cancer, all of whom received 20 mg hydrocortisone twice daily as replacement glucocorticoid."5.05Aminoglutethimide dose and hormone suppression in advanced breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1983)
"The endocrine effects of replacement doses of hydrocortisone in postmenopausal women with advanced breast cancer were compared with the same doses of hydrocortisone plus aminoglutethimide."5.05Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE, 1984)
"Aminoglutethimide (AG) has antitumor activity in disseminated breast cancer similar to that of surgical adrenalectomy."5.05The role of aromatase inhibitors in breast cancer. ( Powles, TJ, 1983)
" Occult hypothyroidism reduces the rate of oestrogen inactivation by C2 hydroxylation, and 15-20% of women have low rates of C16 hydroxylation to oestriol."4.76Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma. ( Lemon, HM, 1980)
"Androstenedione, the main circulating ovarian hormone present after menopause, has been shown to positively correlate with poor spatial memory in an ovary-intact rodent model of follicular depletion, and to impair spatial memory when administered exogenously to surgically menopausal ovariectomized rats."3.81Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats. ( Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW, 2015)
"To describe changes in levels of cognitive symptoms (forgetting and difficulty concentrating) during the menopausal transition (MT) stages and early postmenopause, including effects of age, MT-related factors(MT stages, estrone, follicle stimulating hormone (FSH), testosterone), symptoms (hot flush, sleep, mood), health-related factors (alcohol use, smoking, exercise, perceived health), stress-related factors (perceived stress, history of sexual abuse, cortisol, catecholamines) and social factors (partner and parenting status, education, employment)."3.77Cognitive symptoms during the menopausal transition and early postmenopause. ( Mitchell, ES; Woods, NF, 2011)
"A subset of Seattle Midlife Women's Health Study (SMWHS) participants who provided data during the early reproductive, early and late menopausal transition stages, or postmenopause (n = 286), including menstrual calendars for staging the MT, annual health reports between 1990 and 2005, and morning urine samples assayed for estrone glucuronide (E(1)G), testosterone (T), and follicle-stimulating hormone (FSH) was included."3.76Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. ( Mitchell, ES; Smith-Di Julio, K; Woods, NF, 2010)
" Daily oral MPG (1000 mg/kg body weight) for 2 weeks significantly recovered uterine and adrenal gland atrophy and restored serum estradiol, estrone and progesterone levels that were decreased in rats by bilateral ovariectomy."3.76Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats. ( Chung, MH; Hattori, M; Lu, Y; Ma, H; Nishihara, T, 2010)
"The aims of this study were to examine the association of smoking with the occurrence, frequency, and severity of hot flashes and to determine whether the mechanism by which active cigarette smoking increases the risk of hot flashes is by lowering estradiol and estrone levels."3.73Cigarette smoking, estrogen levels, and hot flashes in midlife women. ( Babus, J; Flaws, JA; Gallicchio, L; Lewis, LM; Miller, SR; Visvanathan, K; Zacur, H, 2006)
" Although angiotensin converting enzyme inhibition has been shown to prevent progression of the disease in postmenopausal women, the interaction of angiotensin II and estrogen in this process before and after the menopause is poorly understood."3.70Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. ( Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H, 1998)
"This study examines the cross-sectional association of hysterectomy and oophorectomy status, chronological age, and years since menopause with plasma levels of total and bioavailable testosterone and estradiol, androstenedione, estrone, and sex hormone-binding globulin (SHBG) in community-dwelling postmenopausal women who were not using estrogen replacement therapy."3.70Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. ( Barrett-Connor, E; Kritz-Silverstein, D; Laughlin, GA; von Mühlen, D, 2000)
"A major obstacle to the understanding of the mechanisms of action of aromatase inhibitors in breast cancer is the observation that plasma estrogens are sustained at about 30-50% of their control levels despite 85-95% inhibition of the conversion of tracer androstenedione (A) to estrone (E1)."3.69A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors. ( Ekse, D; Lønning, PE, 1995)
"Serum dehydroepiandrosterone (DHEA), estrone (E1), and estradiol (E2) levels were prospectively measured in 47 breast cancer patients before and during tamoxifen therapy for 2 years."3.69Changes in serum estrogen levels in women during tamoxifen therapy. ( Fletcher, WS; Lum, SS; Pommier, RF; Woltering, EA, 1997)
"The aim of this study was to investigate the possible role of epidermal growth factor (EGF) and of insulin-like growth factor-I (IGF-I) in physiological and pathological changes of the endometrial tissue during aging."3.68Role of growth factors in the human endometrium during aging. ( Costantini, C; de Cecco, L; Gallo, G; Leone, M; Massajoli, M; Messeni Leone, M; Voci, A, 1993)
"Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase."3.68Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991)
"The effect of tamoxifen on the vaginal mucosa and on serum oestrone, oestradiol and gonadotrophin concentrations was investigated in a group of nine postmenopausal women with non-metastatic breast cancer."3.68Tamoxifen and partial oestrogen agonism in postmenopausal women. ( Burton, R; Castleden, CM; Ekelund, P; Miodrag, A, 1991)
"Values were determined by means of a ligand binding assay using 17-FE (17-fluoresceinated estrone) in 53 breast cancer patients."3.68[Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology]. ( Alamy, H; Baltali, E; Bouih, A; el Gueddari, B; el Hafed, A; Kettani, F; Morchid, M; Souadka, A; Souadka, F; Wydadi, M, 1990)
"Plasma estrone sulphate ( E1S ) and estrone (E1) concentrations were determined in healthy postmenopausal women and in postmenopausal women with endometrial cancer, matched for body weight, age, and years since menopause."3.67Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer. ( Bolelli, G; Bonavia, M; Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM, 1984)
"Plasma androstenedione (A) and oestrone (E1) levels were measured by radioimmunoassay in a group of 78 healthy women who had undergone a natural menopause."3.67Plasma androstenedione and oestrone levels in the climacteric syndrome. ( Battaglia, F; Bini, E; Mango, D; Scirpa, P, 1984)
"Plasma 4-en-androstenedione, testosterone, estradiol and estrone were measured during the day in six healthy postmenopausal women and in six breast cancer patients, three of whom received treatment with glucocorticoids."3.67Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. ( Dowsett, M; Hardy, J; Jacobs, S; Lønning, PE; Powles, TJ; Schem, B, 1989)
"The activities of aromatase and estrone sulfatase which are important enzymes involved in the local production of estrogen in breast cancer tissue were measured to examine their availability in endocrine therapy and their clinical significance."3.67[Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue]. ( Utsumi, T, 1989)
"The endocrine effects of aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily were assessed in 45 postmenopausal women with advanced breast cancer."3.67Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen. ( Cantwell, BM; Dowsett, M; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986)
"The possibility that medroxyprogesterone acetate (MPA) is clinically effective at least in part by its suppression of adrenal steroidogenesis and a resultant reduction of circulating oestrogen levels was investigated in 49 postmenopausal patients with advanced breast cancer."3.67The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. ( Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE, 1987)
" This loss, combined with the low plasma concentrations of androstenedione, dehydroepiandrosterone, and testosterone (and low concentrations of oestrone of adrenal origin), indicates that adrenal androgens may be essential for the maintenance of bone mass in postmenopausal women with Addison's disease."3.67Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. ( Crabbé, J; Devogelaer, JP; Nagant de Deuxchaisnes, C, 1987)
"5 mg, twice a day) aminoglutethimide (AG), without hydrocortisone (HC), escalating at monthly intervals to a conventional dose of AG (500 mg twice a day) combined with HC, were studied in 33 postmenopausal breast cancer patients."3.67Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. ( D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R, 1985)
"The effects of aging as well as body weight on conversion of circulating Androstendione (A) to Estrone (E1) in 21 postmenopausal women of different ages and body weights have been studied."3.67[Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women]. ( Ortega, E; Osorio, C; Ruiz, E, 1988)
"Estrone and estradiol-17 beta concentration in breast cancer tissue are reported to be an order of magnitude higher than those of circulating plasma in breast cancer patients."3.67[Serum estrone sulfate levels in patients with breast cancer]. ( Honjyo, H; Oka, T; Okada, H; Yasumura, T, 1988)
"The results of hCG stimulation on peripheral levels of androstenedione (A), testosterone (T) and estrone (E1) were examined in 14 patients with ovarian tumors and in 9 tumor-free subjects, after the menopause."3.67Response to human chorionic gonadotropin in patients with ovarian tumors. ( Iacona, T; Liberati, M; Mancuso, S; Mango, D; Manna, P; Ricci, S; Scirpa, P; Tartaglia, E, 1988)
"The conversion of 1 beta [3H] androstenedione to estrone in the presence of NADPH by breast cancer homogenates was assessed in tumors from 35 subjects together with estrogen and progesterone receptor concentration."3.67Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. ( Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N, 1987)
"After infusion of 3H-oestradiol or 3H-oestrone into post-menopausal women with breast cancer, there was a significant uptake of both steroids by breast tumour and normal tissue."3.67A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women. ( Beranek, PA; Bonney, RC; Ghilchik, MW; James, VH; McNeill, JM; Reed, MJ; Robinson, DJ, 1986)
"Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status."3.67Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986)
"Oestrone sulphate, the oestrogen in highest concentration in the plasma, may play a role in the induction and growth of breast cancers."3.67Oestrone sulphate, adipose tissue, and breast cancer. ( Hawkins, RA; Killen, E; Thomson, ML, 1985)
"Postmenopausal women with metastatic breast cancer were treated with trilostane, initially 240 mg daily increasing after 3 days to 480 mg daily and after a further three days to 960 mg daily."3.67Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone. ( Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM, 1985)
"Peripheral serum levels of cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulphate (DHA-S), oestradiol-17 beta and total oestrone were measured in 17 postmenopausal breast cancer patients and on age-matched healthy controls."3.66Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. ( Carlström, K; Sköldefors, H; Theve, NO; Wallgren, A; Wilking, N, 1982)
"An analysis of vasomotor, psychological, and physical symptoms of 136 women who were receiving piperazine oestrone sulphate (Ogen) and conjugated equine oestrogens (Premarin) after menopause has shown differences in responses which can be explained only if it is accepted that the two oestrogenic compounds have differing effects on various parts of the body."3.66Differential clinical response to oestrogens after menopause. ( Brown, LB; Routledge, DA; Wren, BG, 1982)
"To investigate the influence of obesity on hormonal parameters in 186 apparently healthy women and in 176 women suffering from severe obesity the serum concentrations of FSH, LH, estrone (E1), estradiol (E2), androstenedione (A) and testosterone (T) were determined radioimmunologically."3.66Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. ( Klinga, K; Runnebaum, B; von Holst, T, 1983)
"Medroxyprogesterone acetate (MPA) was administered orally for at least 6 months to 25 patients with endometrial adenocarcinoma starting 1 week after hysterectomy and bilateral ovariectomy."3.66Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma. ( Backas, NE; Laatikainen, T; Pesonen, K; Stenman, UH; Vesterinen, E, 1981)
"Estradiol receptor (ER) and progesterone receptor (PR) content along with the cytosol and plasma estrone and estradiol levels in 15 premenopausal and 26 postmenopausal women with breast cancer in different clinical stages (T123, N01, M0) were measured."3.66Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level. ( Anghel, C; Drafta, D; Gangură, M; Neacşu, E; Panaitescu, G; Prişcu, A; Schindler, AE; Stroe, E, 1983)
"To evaluate the in vivo effect of delta 1-testololactone on peripheral aromatization, studies were performed on seven postmenopausal women with metastatic breast cancer."3.66In vivo effects of delta 1-testololactone on peripheral aromatization. ( Barone, RM; Gambone, JC; Judd, HL; Lasley, BL; Laufer, LR; Monfort, SL, 1982)
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause."3.66Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982)
" The levels of serum estrone, estradiol and estriol had a tendency of gradual decline after the age of 40, and decreased rapidly 3 years after menopause, but still remained in a certain level thereafter throughout the senile period."3.66[Serum sex steroid hormones in women with aging, and in the patients of climacteric syndrome and squamous cell carcinoma of the uterus]. ( Nishimura, T, 1982)
"Twenty women in the perimenopause were studied for 12 months during which sodium-piperazine-estrone-sulphate 2."3.66Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids. ( Johnson, P; Lagrelius, A; Lunell, NO; Samsioe, G, 1981)
"To study the relation between body weight and height and the plasma sex-hormone levels wer measured the plasma levels of oestrone (E1), oestradiol (E2) and androstenedione (A) in a group of healthy post-menopausal women with a wide range of body weight."3.66Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height. ( de Waard, F; Poortman, J; Thijssen, JH, 1981)
"Circulating estradiol (E2), estrone (E1), adrostenedione, and testosterone levels were measured in 40 normal postmenopausal women of widely varying body weights."3.66Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. ( Deftos, LJ; Frumar, AM; Geola, F; Judd, HL; Meldrum, DR; Shamonki, IM; Tataryn, IV, 1980)
"Plasma levels of oestrone and oestradiol-17beta were determined at 20 or 30 minute intervals for up to 24 hours in 26 postmenopausal or ovariectomised women of similar age, weight, and number of years since menopause or operation."3.66Relation between plasma oestrone and oestradiol and climacteric symptoms. ( Hutton, JD; Jacobs, HS; James, VH; Murray, MA, 1978)
"To study the contribution of adrenal glands to circulating estrogens in woman, the concentrations of estrone (E1), estradiol-17 beta (E2), and estriol (E3) in adrenal and peripheral venous blood were measured by radioimmunoassay and the grandular secretion of estrogens after ACTH stimulation was investigated by analyzing the adrenal vein levels of these steroids in patients with breast cancer who were undergoing a therapeutic adrenal operation."3.66Adrenal contribution to circulating estrogens in woman. ( Akamine, Y; Ibayashi, H; Kato, K; Nomura, Y; Wasada, T, 1978)
"In 55 patients after oophorectomy and 20 women after natural menopause an oral estrogen replacement therapy was performed with estrone-sulfate, estradiol 17-valerate, estriol-succinate, a combination of micronized estradiol and estriol (Estrifam, Trisequens), and natural conjugated estrogens."3.66Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause. ( Goessens, L; Lauritzen, C; Strecker, JR, 1979)
"The daily excretion of estrone, estradiol, and estriol was determined for 22 normal women and 35 women with primary breast cancer."3.66Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. ( Dao, TL; Lonergan, PA; Morreal, CE; Nemoto, T, 1979)
"To determine if delta 1-testololactone can inhibit the peripheral aromatization of androstenedione (delta), nine postmenopausal women with metastatic breast cancer were studied before and after 2 weeks of therapy with 250 mg of the drug, given every 6 h by mouth."3.66Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. ( Barone, RM; Judd, HL; Shamonki, IM; Siiteri, PK, 1979)
"The concentrations of estrone (E1), androstenedione (A), testosterone (T) and sex-hormone-binding globulin (SHBG) in the serum were determined in 122 postmenopausal women, unselected with respect to age and stage of disease and with a newly diagnosed breast cancer."3.66Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. ( Adami, HO; Johansson, ED; Vegelius, J; Victor, A, 1979)
"The purpose of this study was to ascertain if a relationship exists between the transfer constant of conversion of plasma androstenedione to estrone ([rho]AE1BU) and total body weight or excessive body weight in 50 postmenopausal women, of whom 25 had adenocarcinoma of the endometrium and 25 had no endometrial disease."3.66Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. ( Edman, CD; Hemsell, DL; MacDonald, PC; Porter, JC; Siiteri, PK, 1978)
"Plasma sex hormone concentrations (testosterone, (T), androstenedione (A), oestrone (E1) and oestradiol (E2) were measured in forty post-menopausal women more than 4 years post-normal menopause."3.66Sex hormone concentrations in post-menopausal women. ( Verdonck, L; Vermeulen, A, 1978)
"We have infused [6,7-3H]estrone or [6,7-3H]estradiol and [4-14C]estriol into seven women who had had breast cancer and into five normal postmenopausal women."3.66Estriol production rates and breast cancer. ( Longcope, C; Pratt, JH, 1978)
"Fifty-nine postmenopausal women with advanced breast cancer were treated with tamoxifen (antiestrogen), 20 mg orally twice a day for at least 2 months."3.65Tamoxifen (antiestrogen) therapy in advanced breast cancer. ( Kennedy, BJ; Kiang, DT, 1977)
" Firstly, by measuring the excretion of 12 estrogens in pooled human late pregnancy feces before and during the administration of ampicillin (2 g/day)."3.65Intestinal metabolism of estrogens. ( Adlercreutz, H; Dencker, H; Martin, F; Pulkkinen, M; Rimér, U; Sjöberg, NO; Tikkanen, MJ, 1976)
" The estrogens (estriol, estrone, 2-methoxyestrone, estradiol-17beta, estradiol-17alpha, 16-epiestriol, 17-epiestriol, 16-alpha-hydroxyestrone, 16beta-hydroxyestrone, 16oxoestradiol-17beta, and 15alpha-hydroxyestrone) were quantitatively determined in bile from 1 male and 3 postmenopausal women, in the urine of a nonpregnant woman, and in a 20 ml pool of late pregnancy plasma obtained from 10 women."3.65Mass fragmentographic determination of eleven estrogens in the body fluids of pregnant and nonpregnant subjects. ( Adlercreutz, H; Hunneman, DH; Tikkanen, MJ, 1974)
"Glycogen was measured fluorometrically in swab eluate."2.84Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. ( Blair, IA; Cohen, L; Fiedler, T; Fredricks, DN; Freeman, EW; Guthrie, KA; Hoffman, NG; Joffe, H; LaCroix, AZ; Liu, C; Mitchell, CM; Munch, M; Newton, K; Reed, SD; Srinivasan, S; Wu, MC; Zhan, X, 2017)
" The primary pharmacokinetic endpoints were Cmax, AUC(0-t), and AUC(0-inf) for the test and reference products, assessed for bioequivalence using the scaled average bioequivalence or unscaled average bioequivalence method."2.80Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. ( Amadio, JM; Bernick, B; Bon, C; Mirkin, S; Pickar, JH, 2015)
"Letrozole treatment reduced serum estrone (E1) and estradiol (E2) to near undetectable levels (p < 0."2.70Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. ( Heshmati, HM; Khosla, S; Melton, LJ; O'Fallon, WM; Riggs, BL; Robins, SP, 2002)
"1)."2.68[The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women]. ( Pieleszek, A, 1997)
"The pharmacokinetic properties and biotransformation of two orally active oestrogens, piperazine oestrone sulphate (PE1S, 2."2.67Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women. ( Aedo, AR; Diczfalusy, E; Landgren, BM, 1990)
" There was a significant monotonic dose-response relationship of estrone sulfate in raising HDL levels, lowering LDL levels, and raising the HDL/LDL ratio at all intervals measured."2.67Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels. ( Green, EM; Jennings, D; Katz-Karp, S; Lancaster, J; Notelovitz, M; Stoll, RW, 1990)
" The results showed reduced levels of both estrogens in smokers as compared with nonsmokers in all three dosage groups."2.66Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. ( Christiansen, C; Jensen, J; Rødbro, P, 1985)
"Menopause is associated with a significant decline in levels of estrogen, which reportedly leads to several distressing symptoms and adverse health effects on various target tissues including those on bones, heart, and brain."2.43Clinical pharmacology and differential cognitive efficacy of estrogen preparations. ( Asthana, S; Atwood, C; Carlsson, CM; Gleason, CE; Johnson, S, 2005)
" The oestrogen preparations available, the dosage schemes, and the modes of administration are the main aspects of therapy which will be discussed in this paper."2.36Oestrogen therapy in the peri-menopause: A practical approach. ( Haspels, AA, 1980)
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone."2.36Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977)
"Obesity is associated with metabolic dysfunction with sex differences and chronic, low-grade inflammation."1.40Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery. ( Cianflone, K; Lapointe, M; Marceau, P; Rezvani, R; Smith, J; Tchernof, A, 2014)
"Menopause is associated with changes in bone, muscle and fat mass."1.38Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women. ( Armamento-Villareal, RC; Giri, TK; Napoli, N; Nekkalapu, S; Qualls, C; Vattikuti, S; Yarramaneni, J, 2012)
"Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast."1.30Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998)
"Two-hundred and six breast cancer cases were histologically confirmed breast cancer diagnoses at the Cancer Institute in Chennai (Madras), India."1.30A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. ( Gajalakshmi, KC; Ito, Y; Sasaki, R; Shanta, V; Suzuki, K, 1999)
"We have previously shown that human breast cancer is autonomous in the regulation of its intra-tissue oestradiol concentration."1.28On the significance of in situ production of oestrogens in human breast cancer tissue. ( Blankenstein, MA; Daroszewski, J; Donker, GH; Maitimu-Smeele, I; Milewicz, A; Thijssen, JH, 1992)
"Treatment with Danazol had no significant effect on tissue levels of 3H E1S or on the CRE1S E1 or MCR-E1S."1.28The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women. ( Ghilchik, MW; Purohit, A; Reed, MJ; Riaz, AA, 1992)
"Estrone levels were not measurable with a sensitive RIA technique."1.28Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy. ( Heimer, G; Nilsson, K, 1992)
"Estrone was also positively related to androstenedione concentrations (r = 0."1.28Reliability and interrelations among serum sex hormones in postmenopausal women. ( Cauley, JA; Gutai, JP; Kuller, LH; Powell, JG, 1991)
"E1/E2 ratio in cervical cancer patients was higher than that in normal postmenopausal women (P less than 0."1.28[Plasma estrogen level in patients with cervical cancer]. ( Zheng, Y, 1990)
"There was no change in the size of the uterine leiomyomata."1.28Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. ( Baird, DT; Lumsden, MA; West, CP, 1989)
" This study demonstrates that smoking exerts a powerful inducing effect on the 2-hydroxylation pathway of estradiol metabolism, which is likely to lead to decreased bioavailability at estrogen target tissues."1.27Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. ( Bradlow, HL; Fishman, J; Hershcopf, RJ; Michnovicz, JJ; Naganuma, H, 1986)
" Forty-two climacteric women were studied before and after treatment with various drugs at different doses (patients receiving identical compounds served as their own controls for the evaluation of dosage effects; duration of medication: 14 days at each dose)."1.27Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women. ( Hammerstein, J; Moltz, L; Schneller, E; Schwartz, U; Volger, H, 1983)
"5-mg dosage of VCE raised estrone levels to values similar to those in premenopausal women in the late follicular phase, and estradiol concentrations were similar to early follicular phase concentrations."1.27Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. ( Eggena, P; Geola, FL; Hershman, JM; Judd, HL; Lu, JH; Mandel, FP; Meldrum, DR; Sambhi, MP, 1983)
" The most sensitive marker was vaginal cytology, with the E2 dosage reverting the maturation index to premenopausal values."1.27Estrogen replacement therapy by transdermal estradiol administration. ( DeFazio, JL; Eggena, P; Hershman, JM; Judd, HL; Laufer, LR; Lu, JK; Meldrum, DR; Sambhi, MP, 1983)
"Oestrone levels were found to be significantly higher in patients with endometrial carcinoma."1.27Hormonal profile of endometrial cancer. ( Eibschitz, I; Levitan, Z; Oettinger, M; Samberg, I; Sharf, M, 1984)
" A dose-response relation was apparent for these hormones; mean plasma levels increased concomitantly with cigarette consumption."1.27Cigarette smoking and levels of adrenal androgens in postmenopausal women. ( Barrett-Connor, E; Khaw, KT; Tazuke, S, 1988)
"We report two cases of metastatic breast cancer occurring in two postmenopausal women."1.27Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer. ( Guiochet, N; Keiling, R; Schwartz, L, 1988)
"Ketoconazole was poorly tolerated due to gastrointestinal toxicity."1.27High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. ( Cantwell, BM; Dowsett, M; Harris, AL, 1988)
"Naloxone infusion was performed in basal conditions and after chronic oral treatment with conjugated estrogens (CE) (1."1.27Sex steroids modulate prolactin response to naloxone in postmenopausal women. ( Cagnacci, A; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM; Petacchi, FD, 1985)
"We conducted a dose-response study in 23 postmenopausal women to compare the physiologic effects of transdermal estradiol and oral conjugated equine estrogens."1.27Biologic effects of transdermal estradiol. ( Alkjaersig, NK; Chetkowski, RJ; Eggena, P; Fletcher, AP; Hershman, JM; Judd, HL; Lu, JK; Meldrum, DR; Randle, D; Steingold, KA, 1986)
" It was concluded that transdermal administration of E2 at the dosage employed produces a physiological plasma protein distribution of E2 and E1 and does not affect liver protein production."1.27Biological and endocrine aspects of transdermal 17 beta-oestradiol administration in post-menopausal women. ( Bulletti, C; Ciotti, P; Di Cosmo, D; Flamigni, C; Jasonni, VM; Lazzaretto, R; Naldi, S, 1988)
"Estrone levels were independently related to radial bone density."1.27Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures. ( Cauley, JA; Gutai, JP; Kuller, LH; LeDonne, D; Powell, JG; Sandler, RB; Sashin, D, 1988)
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days."1.27Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986)
"When levonorgestrel was used in doses as low as 30 micrograms daily, there was no change in cholesterol levels over a period of 6 mth, suggesting that the adverse effect of the androgenic type progestogens is dose-related and is probably only significant when extremely high dosages are administered."1.27The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women. ( Garrett, D; Wren, B, 1985)
"94 patients with endometrial cancer and double that number of matched controls were examined."1.26Doubts about oestrogen therapy in postmenopausal women. ( , 1976)
"Urinary incontinence was treated conservatively in 100 patients."1.26Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens. ( Kilkku, P; Kiukko, P; Punnonen, R; Rauramo, L, 1981)
" Each dosage of each formulation was ingested by three women."1.26Comparison of pharmacodynamic properties of various estrogen formulations. ( Brenner, PF; Dozono-Takano, R; Eggena, P; Lobo, RA; Mashchak, CA; Mishell, DR; Nakamura, RM, 1982)
" It is concluded that the effects of estrogens on the endocrine system in peri- and postmenopausal women are influenced by chemical structure, dosage and mode of administration of the estrogen as well as by the endogenous hormone profile."1.26Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. ( Carlström, K; Lagrelius, A; Lunell, NO, 1981)
" The dosages of E3 employed appear to vary considerably, and the need was felt to establish the dosage on a scientific basis."1.26The significance of oestriol in the management of the post-menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1980)
"Since unopposed estrogen therapy, as well as overly high doses, has been implicated in increasing the risk for endometrial cancer, this study tried to determine the effect of reducing the daily amount of estrogen and dividing that reduced dosage into 3 daily doses."1.26Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women. ( Lähteenmäki, P; Luukkainen, T; Sipinen, S, 1980)
"Obesity is a physiological state associated with alterations in hormone production and metabolism."1.26Obesity, hormones, and cancer. ( Ertel, N; Kirschner, MA; Schneider, G, 1981)
"To study the effects of exogenous estrogens on the postmenopausal endometrium, and to determine the time course and minimum dosage of added progestins necessary to oppose estrogen stimulation, we obtained endometrial specimens from symptomatic postmenopausal women being treated with various preparations of estrogens and progestins."1.26Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. ( King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI, 1981)
"Crystalline oestradiol-17 beta is poorly absorbed from the gastrointestinal tract."1.26Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes. ( Englund, DE; Johansson, ED, 1981)
"Estrone sulfate levels were measured in the plasma of 63 postmenopausal women."1.26Plasma estrone sulfate levels in postmenopausal women. ( Bleau, G; Chapdelaine, A; Roberts, KD; Rochefort, JG, 1980)
" Requisites of such therapy are a through history to establish a real need, a complete gynecologic examination with a Pap smear before therapy begins and annually afterward, use of the smallest daily dose of estrogen that gives the desired effect, and periodic attempts to reduce the dosage or stop the hormone."1.26Estrogens for the menopause. Maximizing benefits, minimizing risks. ( Seller, JC, 1977)
"Estriol was administered for a six-month period as estrogen replacement therapy to 52 symptomatic postmenopausal women."1.26Estriol in the management of the menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1978)
"Women who had had breast cancer were compared to a group of normal controls and were also found to have similar blood production rates for estriol, estrone, and estradiol."1.26Relationship between urine and plasma estrogen ratios. ( Longcope, C; Pratt, JH, 1978)
"Estrone production was 68 microng/day, most of which could be accounted fo by the extraglandular formation from androstenedione."1.26The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas. ( Aiman, J; Edman, CD; Jacobs, A; MacDonald, PC; Nalick, RH; Porter, JC; Vellios, F, 1977)
"Androstenedione metabolism was studied at the New York Medical College-Metropolitan Hospital Center in 14 patients with endometrial cancer."1.26Androstenedione metabolism in patients with endometrial cancer. ( Calanog, A; Gordon, GG; Sall, S; Southren, AL, 1977)
"When estrone-(3)H was infused, constancy of estrone-(3)H levels was not attained in either the 2-hr infusions or in the two 12-hr infusions."1.25A study of estrogen metabolic clearance rates and transfer factors. ( Bardin, CW; Hembree, WC; Lipsett, MB, 1969)
"In patients with breast and prostate cancer hormone excretion patterns differ in a similar way from patterns in persons without cancer."1.24HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. ( HOPKINS, CE; MARMORSTON, J; STERN, E; WEINER, JM, 1964)

Research

Studies (578)

TimeframeStudies, this research(%)All Research%
pre-1990462 (79.93)18.7374
1990's71 (12.28)18.2507
2000's25 (4.33)29.6817
2010's16 (2.77)24.3611
2020's4 (0.69)2.80

Authors

AuthorsStudies
Napoli, N1
Vattikuti, S1
Yarramaneni, J1
Giri, TK1
Nekkalapu, S1
Qualls, C1
Armamento-Villareal, RC1
Berg, D1
Sonsalla, R1
Kuss, E1
Schinfeld, JS1
Tulchinsky, D2
Schiff, I2
Fishman, J4
Ursin, G1
London, S1
Stanczyk, FZ4
Gentzschein, E1
Paganini-Hill, A2
Ross, RK4
Pike, MC2
Ziegler, RG2
Rossi, SC1
Fears, TR2
Bradlow, HL3
Adlercreutz, H7
Sepkovic, D1
Kiuru, P1
Wahala, K1
Vaught, JB2
Donaldson, JL2
Falk, RT1
Fillmore, CM1
Siiteri, PK12
Hoover, RN2
Gail, MH2
Ho, GH1
Luo, XW1
Ji, CY1
Foo, SC1
Ng, EH1
Westerlind, KC1
Gibson, KJ1
Wolfe, P1
Michnovicz, JJ1
Hershcopf, RJ1
Naganuma, H1
Kling, JM3
Dowling, NM3
Bimonte-Nelson, H3
Gleason, CE4
Kantarci, K3
Stonnington, CM3
Harman, SM5
Naftolin, F3
Pal, L3
Cedars, M3
Manson, JE3
James, TT3
Brinton, EA3
Miller, VM3
Kawakita, T1
Yasui, T3
Yoshida, K1
Matsui, S1
Iwasa, T1
Grummisch, JA1
Sykes Tottenham, L1
Gordon, JL1
Ideno, Y1
Onizuka, Y1
Nakajima-Shimada, J1
Shinozaki, H1
Hayashi, K1
van Winden, LJ1
Kok, M1
Acda, M1
Dezentje, V1
Linn, S1
Shi, RZ1
van Rossum, HH1
Mitchell, CM1
Srinivasan, S1
Zhan, X1
Wu, MC1
Reed, SD1
Guthrie, KA1
LaCroix, AZ1
Fiedler, T1
Munch, M1
Liu, C1
Hoffman, NG1
Blair, IA1
Newton, K1
Freeman, EW1
Joffe, H1
Cohen, L1
Fredricks, DN1
Thurston, RC1
Bhasin, S1
Chang, Y2
Barinas-Mitchell, E1
Matthews, KA3
Jasuja, R1
Santoro, N4
Veldhuis, JD2
Dyer, RB1
Trushin, SA1
Bondar, OP1
Singh, RJ1
Klee, GG1
Woods, NF4
Cray, L1
Mitchell, ES4
Herting, JR1
Rezvani, R1
Smith, J1
Lapointe, M1
Marceau, P1
Tchernof, A1
Cianflone, K1
Mennenga, SE1
Koebele, SV1
Mousa, AA1
Alderete, TJ1
Tsang, CW2
Acosta, JI1
Camp, BW1
Demers, LM3
Bimonte-Nelson, HA2
Pickar, JH1
Bon, C1
Amadio, JM1
Mirkin, S1
Bernick, B1
Swanepoel, AC1
Naidoo, P1
Nielsen, VG1
Pretorius, E1
Crandall, CJ1
Guan, M1
Laughlin, GA2
Ursin, GA1
Ingles, SA1
Barrett-Connor, E3
Greendale, GA3
COULTON, D1
SEWALL, CW1
Finni, T1
Kovanen, V1
Ronkainen, PH1
Pöllänen, E1
Bashford, GR1
Kaprio, J1
Alén, M1
Kujala, UM1
Sipilä, S1
O'Connor, KA1
Ferrell, RJ1
Brindle, E1
Shofer, J1
Holman, DJ1
Miller, RC1
Schechter, DE1
Singer, B1
Weinstein, M1
Lønning, PE4
Helle, H1
Duong, NK1
Ekse, D3
Aas, T1
Geisler, J1
Smith-Di Julio, K1
Ma, H1
Chung, MH1
Lu, Y1
Nishihara, T1
Hattori, M1
Shimizu, Y2
Franklin, SL1
Engler-Chiurazzi, EB1
Talboom, JS1
Braden, BB1
Mennenga, S1
Andrews, M1
Wilborn, WH1
Hyde, BM1
Vardy, MD1
Lindsay, R1
Scotti, RJ1
Mikhail, M1
Richart, RM1
Nieves, J1
Zion, M1
Cosman, F1
BERGER, J1
KELLER, M1
CALDERON DE LAGUNA, J1
AGUILAR, OR1
SCIARRA, F1
LUCHETTI, L1
DE FELICE, M1
RAURAMO, L4
GROENROOS, M1
NISSEN-MEYER, R3
SANNER, T1
LEMON, HM4
PARSONS, L2
MOZDEN, PH1
KECSKES, L1
KOBOR, J1
MUTSEHLER, F1
LAURITZEN, C4
STERN, E2
HOPKINS, CE2
WEINER, JM1
MARMORSTON, J2
BARANOV, VG1
BLAGOSKLONNAIA, IaV1
NIKOLAENKO, NF1
PODOLSKAIA, IIu1
RAFALSKII, IaD1
ROZOVSKAIA, IT1
SAVCHENKO, ON1
STEPANOV, GS1
SKOLOV, EG1
MOZDEN, PJ1
PERSSON, BH1
RISHOLM, L1
ROSNER, F1
LEE, SL1
OLINA, A1
CROWLEY, LG1
MYERS, SM1
BIRNBERG, CH1
SHERBER, DA1
BRANDMAN, LJ1
Lasley, B2
McConnell, D2
Allsworth, J1
Crawford, S3
Gold, EB2
Finkelstein, JS1
Kelsey, J1
Korenman, S1
Luborsky, JL3
Matthews, K1
Midgley, R1
Powell, L2
Sabatine, J1
Schocken, M1
Sowers, MF2
Weiss, G3
HAHN, H1
Sharp, L1
Cardy, AH1
Cotton, SC1
Little, J1
Noh, JJ1
Maskarinec, G1
Pagano, I1
Cheung, LW1
Carlsson, CM1
Johnson, S1
Atwood, C1
Asthana, S1
Kavanagh, K1
Koudy Williams, J1
Wagner, JD1
Gallicchio, L1
Miller, SR1
Visvanathan, K1
Lewis, LM1
Babus, J1
Zacur, H1
Flaws, JA1
Wright, JV1
Pasternak, RC1
Sutton-Tyrrell, K1
Sowers, M2
Lebrun, CE1
van der Schouw, YT1
de Jong, FH1
Pols, HA1
Grobbee, DE1
Lamberts, SW1
Curcio, JJ1
Wollner, DA1
Schmidt, JW1
Kim, LS1
Meyer, PM1
Zeger, SL1
Harlow, SD1
Janssen, I1
McConnell, DS1
Randolph, JF2
Bochkareva, NV1
Kondakova, IV1
Kolomiets, LA1
Muntyan, AB1
Shevchenko, VP1
Nagaev, IY1
Shevchenko, KV1
Myasoedov, NF1
Dorofeeva, NN1
Smith-DiJulio, K1
Percival, DB1
Tao, EY1
VOGEL, M1
McGAVACK, TH1
MELLOW, J1
Crawford, SL1
Lasley, WL1
Korenman, SG1
Whittaker, PG1
Morgan, MR1
Dean, PD1
Cameron, EH1
Lind, T1
Masarei, JR1
Armstrong, BK1
Skinner, MW1
Ratajczak, T1
Hähnel, R1
Crooke, D1
Clarke, HT1
Grönroos, M4
Kauppila, O1
Pulkkinen, M2
Turunen, S1
Salmi, T1
Raekallio, J1
Varma, TR4
Morsman, J1
Kapetanakis, E1
Dmowski, WP1
Auletta, F1
Scommegna, A1
Coombes, RC4
Chilvers, C1
Dowsett, M17
Gazet, JC2
Ford, HT1
Bettelheim, R1
Gordon, C1
Smith, IE9
Zava, D1
Powles, TJ4
Wilking, N2
Carlström, K19
Sköldefors, H1
Theve, NO1
Wallgren, A1
Adami, HO4
Axelsson, O1
Vegelius, J2
Akerström, G1
Harris, AL10
Jeffcoate, SL5
Pelusi, G3
Moretti, B2
Martinelli, G2
Camerini, T1
Busacchi, P2
Cavallina, R2
Brody, S3
von Uexküll, AK2
Lagrelius, A6
Lunell, NO7
Rosenborg, L3
Bonney, RC4
Scanlon, MJ2
Reed, MJ16
Jones, DL2
Beranek, PA7
James, VH18
Jeffcoate, S1
Stuart-Harris, RC1
Paterson, ME1
Sturdee, DW1
Moore, B1
Whitehead, TP1
Bhavnani, BR2
Sarda, IR1
Woolever, CA1
King, RJ4
Townsend, PT4
Whitehead, MI7
Towobola, OA1
Crilly, RC1
Oakey, RE1
Luisi, M2
Franchi, F2
Kicovic, PM1
Hintz, BL1
Kagan, AR1
Gilbert, HA1
Rao, AR1
Chan, P1
Nussbaum, H1
Coope, J1
Helgason, S4
Damber, MG7
Damber, JE2
Selstam, G2
von Schoultz, B12
Punnonen, R4
Kilkku, P1
Kiukko, P1
Stigbrand, T2
Mashchak, CA1
Lobo, RA3
Dozono-Takano, R1
Eggena, P4
Nakamura, RM2
Brenner, PF2
Mishell, DR2
Wren, BG2
Brown, LB1
Routledge, DA1
Samojlik, E8
Santen, RJ8
Worgul, TJ2
Schwartz, U1
Volger, H1
Schneller, E1
Moltz, L1
Hammerstein, J1
Mandel, FP1
Geola, FL1
Meldrum, DR5
Lu, JH1
Sambhi, MP2
Hershman, JM3
Judd, HL16
Routledge, AD1
Davidson, K1
McCormick, W1
Singer, F1
Roy, S2
Jasonni, VM8
Bulletti, C9
Bolelli, GF3
Franceschetti, F6
Bonavia, M6
Ciotti, P8
Flamigni, C9
Laufer, LR3
DeFazio, JL1
Lu, JK2
Falsetti, L1
Omodei, U1
Dordoni, D1
Scagliola, P1
Turla, R1
Zotti, L1
Archetti, L1
Klinga, K3
von Holst, T3
Runnebaum, B3
Yoshimoto, S1
Fujita, T1
Tataryn, IV2
Frumar, AM3
Erlik, Y1
Lu, KH1
Crilly, RG4
Francis, RM1
Nordin, BE8
Marshall, DH7
Barkworth, SA1
Wells, SA4
Lucisano, A2
Acampora, MG2
Russo, N2
Maniccia, E2
Montemurro, A3
Dell'Acqua, S2
Vermeulen-Meiners, C2
Jaszmann, LJ1
Haspels, AA3
Poortman, J9
Thijssen, JH16
Longcope, C16
Baker, RS2
Hui, SL4
Johnston, CC7
Friedrich, EG1
Kalra, PS2
Prost, O2
Turrel, MO1
Dahan, N1
Craveur, C1
Adessi, GL2
Holst, J3
Einhorn, N1
Fredricsson, B1
Sundelin, P1
Davidson, BJ3
Lagasse, LD2
Cheng, RW1
Noel, CT3
Dudley, HA1
Mattsson, LA1
Abrahamsson, L1
Cullberg, G1
Samsioe, G2
Bolelli, G2
Guerami, A1
MacDonald, PC6
Casey, ML1
Wiegerninck, MA1
Donker, GH3
Oettinger, M1
Samberg, I1
Levitan, Z1
Eibschitz, I1
Sharf, M1
Mango, D6
Scirpa, P6
Battaglia, F4
Bini, E1
Jasonni, M1
Armani, A1
Shoupe, D1
Paul, W1
Kasai, T1
Takeda, B1
Takamizawa, H1
Tzingounis, VA2
Aksu, MF2
Greenblatt, RB3
Sipinen, S4
Lähteenmäki, P3
Luukkainen, T2
Drafta, D2
Schindler, AE3
Milcu, SM1
Keller, E1
Stroe, E2
Horodniceanu, E1
Bălănescu, I1
Sitruk-Ware, R1
de Lignieres, B2
Basdevant, A2
Mauvais-Jarvis, P1
Keller, PJ3
Riedmann, R2
Fischer, M2
Thom, MH2
Collins, WP6
Studd, JW4
Vesterinen, E1
Backas, NE1
Pesonen, K1
Stenman, UH1
Laatikainen, T1
Gerber, C1
Dyer, GI1
Young, O1
Englund, DE4
Victor, A2
Johansson, ED6
Argenio, GF1
Barletta, D1
Romano, MR1
Bernini, GP1
Gasperi, M1
Sgrilli, R1
Fiet, J1
Hermano, M1
Witte, J1
Villette, JM1
Haimart, M1
Gourmel, B1
Tabuteau, F1
Rouffy, J1
Dreux, C1
Wollesen, F1
Knigge, U1
Larsen, K1
Fåhraeus, L1
Larsson-Cohn, U2
Prişcu, A1
Neacşu, E1
Gangură, M1
Anghel, C1
Panaitescu, G1
Trichopoulos, D2
Polychronopoulou, A1
Brown, J2
MacMahon, B2
Rémy-Martin, A1
Nicollier, M1
Burnod, J1
Cajander, S1
Schneider, J1
Anderson, KE1
Kappas, A1
Aiman, J3
Heinonen, PK1
Tuimala, R1
Pyykkö, K2
Pystynen, P2
Shamonki, IM3
Kirschner, MA7
Ertel, NH1
Barone, RM3
Gambone, JC1
Monfort, SL1
Lasley, BL4
Scirpa, S2
Södergård, R1
de Waard, F5
de Pedro-Alvarez Ferrero, M1
Baanders-van Halewijn, EA1
Cole, P1
Nishimura, T1
Rezaković, D1
Jovanović, V1
Ferraretti, AP1
Fuschini, G1
De March, A1
La Marca, L2
Jacobs, HS7
Hammond, GD1
Johnson, P1
Jaffee, W2
Griffing, G2
Vilska, S1
Ertel, N1
Schneider, G1
Lane, G1
Dyer, G2
Zumoff, B1
Strain, GW1
Kream, J1
O'Connor, J2
Levin, J1
Fukushima, DK2
Braunsberg, H1
Short, F1
Dias, VO1
Baxendale, PM2
Pryse-Davies, J1
Ryder, TA1
Folkerd, EJ1
Lodi, S1
Preti, S1
Geola, F1
Deftos, LJ1
Riggs, BL3
Coulam, CB1
Toft, DO1
Klemi, PJ1
Roberts, KD1
Rochefort, JG1
Bleau, G1
Chapdelaine, A2
Dzieciuchowicz, L2
Lyrenäs, S1
Bäckström, T1
Uemura, H1
Yoneda, N1
Irahara, M1
Aono, T1
Sunahara, S1
Hata, K1
Leone, M1
Costantini, C1
Gallo, G1
Voci, A1
Massajoli, M1
Messeni Leone, M1
de Cecco, L1
Rannevik, G2
Jeppsson, S3
Johnell, O1
Bjerre, B2
Laurell-Borulf, Y1
Svanberg, L2
Wysowski, DK1
Golden, L1
Burke, L1
Pansini, F1
Albertazzi, P1
Bonaccorsi, G1
Calisesi, M1
Campobasso, C1
Zanotti, L1
Bagni, B1
Mollica, G1
Massobrio, M1
Migliardi, M1
Cassoni, P1
Menzaghi, C1
Revelli, A1
Cenderelli, G1
Svensson, LO1
Johnson, SH1
Olsson, SE1
Söderqvist, G1
Olsson, H1
Iveson, TJ1
Ahern, J1
Smithers, DA1
Trunet, PF1
Casper, RF2
Noguchi, T1
Kitawaki, J1
Tamura, T1
Kim, T1
Kanno, H1
Yamamoto, T1
Okada, H2
Chandler, DW1
Hyer, MB1
Pee, D1
Ricker, WV1
Bancroft, J1
Cawood, EH1
Lum, SS1
Woltering, EA1
Fletcher, WS1
Pommier, RF1
Gilardi, KV1
Shideler, SE3
Valverde, CR1
Roberts, JA1
Blaakaer, J1
Pieleszek, A1
Grohé, C1
Kahlert, S1
Löbbert, K1
Neyses, L1
van Eickels, M1
Stimpel, M1
Vetter, H1
Abplanalp, W1
Rymaszewski, M1
Adamski, J1
Subbiah, MT1
Ito, Y1
Gajalakshmi, KC1
Sasaki, R1
Suzuki, K1
Shanta, V1
Kritz-Silverstein, D1
von Mühlen, D1
Yanaihara, T2
Haiman, CA1
Hankinson, SE2
Spiegelman, D1
De Vivo, I2
Colditz, GA2
Willett, WC1
Speizer, FE1
Hunter, DJ2
Brennan, JJ1
Lu, Z1
Whitman, M1
Stafiniak, P1
van der Hoop, RG1
Gee, NA1
Chen, J1
Heshmati, HM1
Khosla, S1
Robins, SP1
O'Fallon, WM1
Melton, LJ2
Nand, SL1
Webster, MA1
Baber, R1
Heller, GZ1
Li, L1
Pollow, K1
Boquoi, E1
Baumann, J1
Schmidt-Gollwitzer, M2
Pollow, B1
Rose, DP3
Davis, TE1
Miller, WR2
Hawkins, RA3
Creel, RJ1
Forrest, AP1
Hutton, JD5
Murray, MA3
Daniell, HW1
Rimsten, A2
Wide, L1
Veldhuis, J2
Lipton, A3
Harvey, H3
Hill, P1
Wynder, EL1
Helman, P1
Hickman, R1
Rona, G1
Kuno, K1
Maroulis, GB2
Abraham, GE2
Sansone-Bazzano, G1
Seeler, AK1
Cummings, B1
Reisner, RM1
Furuhjelm, M4
Joelsson, I1
Kontula, K1
Jänne, O1
Vihko, R2
de Jager, E1
de Visser, J1
Zeelen, F1
Schwarz, F2
Vermeulen, A4
Sakai, F1
Saez, S2
Studd, J1
Fern, M1
Liskowski, L1
Milbrath, JR1
Ruby, EB1
Kendall, J1
Seller, JC1
Wasada, T1
Akamine, Y1
Kato, K1
Ibayashi, H1
Nomura, Y1
Kruyver, GP1
Beard, RW1
Dickerson, J1
Bressler, R1
Christian, CD1
Hermann, HW1
Strecker, JR1
Goessens, L1
Franz, C2
Watson, D1
Santner, S1
Davis, B1
Ruby, E1
Morreal, CE2
Dao, TL3
Nemoto, T1
Lonergan, PA1
Crilly, R3
Horsman, A1
Knab, DR1
Schneider, WH1
Spona, J1
Schneider, HP1
Pinkus, JL1
Charles, D1
Chattoraj, SC1
Lynch, HT1
Trolp, R1
Breckwoldt, M1
Hoff, A1
Verdonck, L3
Fisher, RP1
Lillienberg, L1
Svanborg, A1
de Thibault de Boesinghe, L1
Eechaute, W1
Lacroix, E1
Little, B1
Billiar, RB1
Jassani, M1
Papadaki, L1
Beilby, JO1
Chowaniec, J1
Coulson, WF1
Darby, AJ1
Newman, J1
O'Shea, A1
Wykes, JR1
Morse, AR1
Cohen, FB1
Ryan, C1
Lipsett, MB2
Isaacs, AJ1
Havard, CW1
Andriesse, R1
Thussen, JH1
Deutsch, S1
Benjamin, F1
Pelc, B1
Guha, P1
Khan, MY1
Edman, CD3
Hemsell, DL1
Porter, JC2
Kågedal, B1
Wallentin, L1
Goodall, A1
Baxendale, P1
Varela, RM1
Woytoń, J1
Sward, J1
Weiland, AJ1
Bookstein, JJ1
Cleary, RE1
Martin, PM1
Chouvet, CD1
Pratt, JH2
Cawood, M1
Bird, CE1
Finnis, W1
Boroomand, K1
Murphy, J1
Clark, AF1
Chakravarti, S2
Badawy, SZ1
Elliott, LJ1
Elbadawi, A1
Marshall, LD1
Aylward, M2
Maddock, J1
Rees, P1
Hackman, BW1
Galbraith, D1
Thomson, J1
Lee, SG1
Lundy, LE1
Kashef, M1
Dorn, J1
McEwan, HP1
Monroe, SE1
Menon, KM1
Wu, CH1
Gambrell, RD2
Asch, RH1
Nalick, RH1
Jacobs, A1
Vellios, F2
Gross, J1
Modan, B1
Bertini, B1
Spira, O1
Vestergaard, P1
Ryan, KJ1
Nagamani, M2
Lin, TJ1
McDonough, PG1
Watatani, H1
McPherson, JC1
Mahesh, VB1
Calanog, A1
Sall, S1
Gordon, GG1
Southren, AL1
Kiang, DT1
Kennedy, BJ1
Grodin, JM2
Lucas, WE2
Yen, SS3
Martin, F1
Dencker, H1
Rimér, U1
Sjöberg, NO1
Tikkanen, MJ2
Bulbrook, RD1
Swain, MC1
Wang, DY1
Hayward, JL1
Kumaoka, S1
Takatani, O1
Abe, O1
Utsunomiya, J1
Forecast, JD1
Newton, JR1
Oram, DH1
Mesnard, F1
Stone, SC1
Mickal, A1
Rye, PH1
Grattarola, R2
Secreto, G2
Recchione, C2
Daw, E2
Martin, PL1
Burnier, AM1
Czekala, NM2
Greaney, MO1
Callantine, MR1
Andrews, MC1
Wentz, AC1
Rizkallah, TH1
Tovell, HM1
Kelly, WG1
Leyendecker, G1
Geppert, G1
Nocke, W1
Ufer, J1
Tominaga, T1
Tei, N1
Kitamura, M1
Taguchi, T1
Azuma, Y1
Ziel, HK1
Finkle, WD1
Weiss, NS1
Szekely, DR1
Austin, DF1
Bohdanowicz-Pawlak, A1
Milewicz, A4
Amałowicz, B1
Tupikowska, G1
Bolanowski, M1
Blankenstein, MA4
Maitimu-Smeele, I1
Daroszewski, J3
Owen, EJ1
Siddle, NC1
McGarrigle, HT1
Pugh, MA1
Purohit, A1
Riaz, AA1
Ghilchik, MW5
van der Mooren, MJ1
Demacker, PN1
Thomas, CM1
Rolland, R1
Nilsson, K2
Heimer, G2
Phillips, SM1
Sherwin, BB4
Jurgens, RW1
Downey, LJ1
Abernethy, WD1
Cutler, NR1
Conrad, J1
Mancini, A2
di Pietro, C2
de Marinis, L2
Rossi, S2
Lombardi, CP2
Iacona, T2
Bellantone, R2
Liberale, I2
Menini, E2
Crucitti, F2
Szymczak, J1
Reginster, JY2
Deroisy, R2
Fontaine, MA1
Franchimont, P2
Lynch, J1
Mulagha, M1
Hanagan, J1
Garber, JE1
Henderson, IC1
Navari, RM1
Goldman, M1
Connolly, JM1
Strong, LE1
Regensteiner, JG1
Hiatt, WR1
Byyny, RL1
Pickett, CK1
Woodard, WD1
Moore, LG1
Mehta, A2
Cantwell, BM6
Eichner, JE1
Friedrich, CA1
Cauley, JA6
Kamboh, MI1
Gutai, JP7
Kuller, LH7
Ferrell, RE1
Cagnacci, A2
Melis, GB2
Soldani, R1
Paoletti, AM2
Gambacciani, M2
Spinetti, A1
Fioretti, P2
Rae, MH3
Mole, PA3
Paterson, CR3
Bellantoni, MF2
Cho, DE1
Blackman, MR2
Becker, U2
Almdal, T1
Christensen, E1
Gluud, C2
Farholt, S2
Bennett, P3
Svenstrup, B3
Hardt, F2
Micic, S2
Cullins, VE1
Engelhardt, SM1
Miodrag, A1
Ekelund, P1
Burton, R1
Castleden, CM1
Powell, JG4
Austin, H1
Austin, JM1
Partridge, EE1
Hatch, KD1
Shingleton, HM1
Bagdade, JD1
Subbaiah, PV1
Ohta, H1
Suda, Y1
Makita, K1
Nozawa, S1
Nemoto, K1
Zheng, Y1
Herbert, PN1
McKinlay, SM1
Goldfield, SR1
Schlemmer, A1
Jensen, J6
Riis, BJ4
Christiansen, C8
Nilas, L1
Aedo, AR3
Landgren, BM3
Diczfalusy, E3
Stein, RC2
Suranyi-Cadotte, BE1
Notelovitz, M2
Katz-Karp, S1
Jennings, D1
Lancaster, J1
Green, EM1
Stoll, RW1
Shimizu, H1
Bernstein, L1
Henderson, BE1
Colvin, PL1
Auerbach, BJ1
Koritnik, DR1
Hazzard, WR1
Applebaum-Bowden, D1
Baltali, E1
Souadka, A1
el Hafed, A1
Wydadi, M1
Kettani, F1
Alamy, H1
el Gueddari, B1
Morchid, M1
Bouih, A1
Souadka, F1
Liberati, M2
Manna, P3
Ricci, S2
Mancuso, S2
DeVane, GW1
Benirschke, K1
Carmichael, J2
Le Donne, M1
Sundén, M1
Pattison, NS1
Uptin, T1
Knox, B1
France, J1
Lumsden, MA1
West, CP1
Baird, DT2
Jacobs, S1
Schem, B1
Hardy, J1
Yamagata, S1
Yamamoto, K2
Tsuchida, S1
Kawamura, N1
Matsumoto, Y1
Ueki, S1
Sugawa, T1
Bruning, PF1
Bonfrer, JM1
Hart, AA1
van der Linden, E1
de Jong-Bakker, M1
Moolenaar, AJ1
Nooijen, WJ1
LeDonne, D2
Pschera, H1
Hjerpe, A1
Tait, GH1
Newton, CJ2
Donát, J1
Jirkalová, V1
Utsumi, T1
Cunningham, DC1
Evans, S1
Dehennin, L1
Hedley, A1
Albert, A2
Denis, D1
Lecart, MP1
Collette, J1
Stuart-Harris, R2
Hill, M1
van Landeghem, AA2
Goss, PE1
Hutchison, G1
Brodie, AM1
Sainsbury, JR1
Needham, G1
Farndon, J1
Wilson, R1
Friedman, AJ1
Ravnikar, VA1
Barbieri, RL1
Lal, A1
Devogelaer, JP1
Crabbé, J1
Nagant de Deuxchaisnes, C1
Khaw, KT1
Tazuke, S1
Pugeat, M1
Lejeune, H1
Mazenod, B1
Dechaud, H1
Fleury, MC1
Tourniaire, J1
Schwartz, L1
Guiochet, N1
Keiling, R1
Everard, D1
Hole, D1
D'Souza, A1
Donaldson, A1
Düsterberg, B1
Hümpel, M1
Powers, MS1
Schenkel, L1
Darley, PE1
Good, WR1
Balestra, JC1
Place, VA1
Mais, V1
Petacchi, FD1
Chetkowski, RJ1
Steingold, KA1
Randle, D1
Alkjaersig, NK1
Fletcher, AP1
Folan, J1
Gosling, JP1
Fottrell, PF1
Thomas, G1
Thalabard, JC1
Mercier-Bodard, C1
Conard, J1
Guyene, TT2
Mairon, N1
Corvol, P1
Guy-Grand, B1
Tan, YM1
Steele, PA1
Judd, SJ1
Rødbro, P3
Karlsson, S1
Kullander, S1
Morello, C1
Baker, R1
Dahl, KD1
Lim, P1
Hsueh, AJ1
Trévoux, R1
De Brux, J1
Castanier, M1
Nahoul, K1
Soule, JP1
Scholler, R1
Grün, R1
Günther, C1
Kaffarnik, H1
Tsai, CC1
Semmens, JP2
Semmens, EC1
Lam, CF1
Lee, FS1
Wilson, PD1
Faragher, B1
Butler, B1
Bu'Lock, D2
Robinson, EL1
Brown, AD1
Fink, B1
Moller, S1
Alapin-Rubillovitz, S1
Ortega, E1
Ruiz, E1
Osorio, C1
Karlgren, E1
Yasumura, T1
Oka, T1
Honjyo, H1
Helin, HJ1
Isola, JJ1
Helle, MJ1
Kuang, AK1
Naldi, S3
Di Cosmo, D1
Lazzaretto, R1
Sandler, RB2
Sashin, D2
Tartaglia, E2
Wu, FR1
Kauppila, A1
Kivinen, S1
Stenbäck, F1
Vuopala, S1
Nagasako, S1
Asanuma, N1
Nagata, Y1
Hassager, C1
Strøm, V1
Hagerty, MA1
Howie, BJ1
Tan, S1
Shultz, TD1
Fantl, JA1
Wyman, JF1
Anderson, RL1
Matt, DW1
Bump, RC1
Jokela, H1
Kudo, R1
Punnonen, K1
Simberg, N1
Murai, J2
Ernster, VL1
Wrensch, MR1
Petrakis, NL1
King, EB1
Miike, R1
Goodson, WH1
Slemenda, C1
Bezwoda, WR1
Mansoor, N1
Dansey, R1
Esser, JD1
Cobb, JO1
Wahner, HW1
Richelson, LS1
Offord, KP1
Fabiano, A1
Fattibene, M1
Parlati, E1
Samuel, DL1
Forney, JP1
Parker, CR1
McNeill, JM1
Robinson, DJ1
Matsumine, H1
Hirato, K1
Tamada, T1
Yoshida, M1
Evans, WS1
Rogol, AD1
Ridgeway, CE1
Crowley, WF1
Kolp, L1
Checinska, E1
Thorner, MO1
Kvinnsland, S1
Thorsen, T1
Vignudelli, A1
Puolakka, J1
Lahti, A1
Viinikka, L1
Ylikorkala, O1
LaPorte, RE1
Falch, JA1
Oftebro, H1
Haug, E1
Gelfand, MM1
Kano, T1
Nishikawa, K1
Mathur, RS1
Landgrebe, SC1
Moody, LO1
Williamson, HO1
Wren, B1
Garrett, D1
Witt, RM1
Appledorn, R1
Enriori, CL1
Orsini, W1
del Carmen Cremona, M1
Etkin, AE1
Cardillo, LR1
Reforzo-Membrives, J1
Hannigan, EV1
Dillard, EA1
Van Dinh, T1
Hummer, L1
Nabuurs, M1
Thomson, ML1
Killen, E1
Whitworth, NS1
Meeks, GR1
Mason, RC1
Beardwell, CG1
Hindley, AC1
Wilkinson, PM1
St John, J1
Argüelles, AE1
Poggi, UL1
Saborida, C1
Hoffman, C1
Chekherdemian, M1
Blanchard, O1
Oertel, GW1
Menzel, P1
Procopé, BJ4
Howard, RP1
Keaty, EC1
Lozman, H1
Barlow, AL1
Levitt, DG1
Stone, S1
Kharma, KM1
Thorneycroft, IH1
Fechner, RE1
Willcox, PA1
Thomas, GH1
Saez, JM1
Morera, AM1
Dazord, A1
Bertrand, J1
Coertz, GR1
Crepy, OC1
Judas, OE1
Longchampt, JE1
Jayle, MF1
Hunneman, DH1
Widholm, O1
Vartiainen, E1
Holly, F1
Parker, RJ1
Cooper, W1
Marnie, M1
Iakovleva, VV1
Judd, GE1
Göretzlehner, G1
Kyank, H1
Herre, HD1
Töwe, J1
Fahmy, N1
Frandsen, VA1
Nakayama, T1
Brown, JB1
Beischer, NA1
Warner, PO1
Delvoye, P1
Vekemans, M1
Calaf, J1
L'Hermite, M1
Robyn, C1
Hausknecht, RU2
Gusberg, SB2
Rader, MD1
Flickinger, GL1
DeVilla, GO1
Mikuta, JJ1
Mikhail, G1
Jiang, NS1
Ryan, RJ1
Abdel-Aziz, MT1
Abdel-Kader, MM1
Khattab, M1
Saleh, SA1
Gobba, S1
Taema, H1
Gläser, F1
Ebert, A1
Kurt, H1
Friedrich, E1
Castellini, W1
Pratt, JJ1
van der Linden, G1
Doorenbos, H1
Woldring, MG1
Cedard, L1
Heilbronner, N1
Schnirer, J1
Fontenay, M1
Varangot, J1
Taylor, JP2
Kaplan, HG1
Hreshchyshyn, MM1
Dapunt, O1
Gleispach, H1
Daxenbichler, G1
Knorr, DW1
Grudzień, M1
Lambillon, J1
Stern, MI1
Loraine, JA3
Adamopoulos, DA2
Seddon, RJ1
Dove, GA3
Morley, F1
Batchelor, A1
Lunn, SF1
Veeman, W1
Dilman, VM1
Berstein, LM1
Bobrov, YF1
Bohman, YV1
Kovaleva, IG1
Krylova, NV1
Konoplia, EF1
Aho, AJ1
Guevara, A1
Goldfarb, AF1
Papanicolaou, AD1
Hembree, WC1
Bardin, CW1
Ludwig, E1
Buzzoni, P1
Ingrassia, F1
Bonfirraro, G1

Clinical Trials (13)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women[NCT00154180]Phase 4728 participants (Anticipated)Interventional2005-09-30Active, not recruiting
Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy[NCT05122065]432 participants (Anticipated)Observational2021-12-01Not yet recruiting
A Multicenter, Open-label Randomized Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of Nestorone® and Estradiol (NES-E2 CVR).[NCT03432416]Phase 2300 participants (Anticipated)Interventional2018-02-12Recruiting
A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating[NCT04278755]Phase 28 participants (Actual)Interventional2020-09-24Terminated (stopped due to Halted prematurely due to COVID-19-related enrollment challenges.)
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model[NCT04051320]Phase 223 participants (Actual)Interventional2020-01-02Completed
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women Comprehensive Longitudinal Assessment of Release With Estradiol Pellet Analysis (CLARA Study)[NCT06136208]25 participants (Anticipated)Interventional2023-10-27Recruiting
Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol[NCT03868202]Phase 210 participants (Anticipated)Interventional2019-07-03Recruiting
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass[NCT01928082]Phase 21 participants (Actual)Interventional2013-08-01Terminated (stopped due to The fellow conducting the recruitment and screening left the institution)
Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms[NCT00603967]151 participants (Actual)Interventional2006-03-31Completed
The Effects of Testosterone and Nutritional Supplementation, Alone and Combined, on the Adverse Effects of Under-Nutrition in the Elderly[NCT00117000]Phase 3200 participants Interventional2003-07-31Active, not recruiting
Effectiveness of Physiotherapy Treatment to Improve the Flow on Vascular Area of the Endometrial / Subendometrial in Uterus of Infertile Women With Hypoestrogenemia Evaluated by Three-dimensional Ultrasound Angiography.[NCT02437435]54 participants (Actual)Interventional2018-08-01Completed
[NCT00005223]0 participants Observational1988-04-30Completed
Effect of DHEA on Skin Aging - Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.[NCT00248989]Phase 3150 participants (Actual)Interventional2004-11-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Pre-intervention to Intervention Endpoint in Behavioral Inhibition Subscale Score

The Behavioral Inhibition/Behavioral Activation questionnaire will be used to assess behavioural inhibition (BI). The minimum score on the BI subscale is 7, maximum 28. Greater scores indicate greater BI. Change is defined as the average change in BI from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC1.43

Change From Pre-intervention to Intervention Endpoint in Binge Eating Sum Score

"Binge eating will be measured using the 8-item binge eating subscale of the Eating Pathology Symptoms Inventory (EPSI), which measures features of binge eating (e.g., consumption of large quantities of food, mindless eating) on a 5-point Likert scale from never to very often. The EPSI scale is designed to assess behavior over the past 28 days. Items are summed for a scale score ranging from 0-32. Higher scores indicate more frequent experiences with binge eating behavior. Change is defined as the average change in the binge eating scale score from pre-intervention to intervention." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC-6.60

Change From Pre-intervention to Intervention Endpoint in Delay Discounting Parameter k

The Monetary Choice Questionnaire will be used to measure delay discounting. Participants will be asked to make a series of hypothetical choices between small, sooner (impulsive) vs. larger, later (self controlled) hypothetical monetary outcomes. k is a hyperbolic function with larger k values indicating more valuation of a larger delayed reward and smaller values indicating preference for more immediate, smaller rewards (more impulsivity). k can range from 0 to .25 with scores of .25 indicating complete valuation of the immediate reward and 0 indicating complete valuation of the larger, delayed reward. Change is defined as the average change in k from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionk value (Mean)
Continuous OC.01

Change From Pre-intervention to Intervention Endpoint in Nucleus Accumbens Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Nucleus Accumbens (NAcc) reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
Continuous OC.0423

Change From Pre-intervention to Intervention Endpoint in Prefrontal Cortex Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Prefrontal cortex reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
Continuous OC.01

Change From Pre-intervention to Intervention Endpoint in Self-reported Reward Sensitivity Subscale Score

Sensitivity to Punishment/Sensitivity to Reward Questionnaire will be used to measure reward sensitivity. The reward sensitivity subscale will be used, which is rated on a true/false scale with scores ranging 0-24. Higher scores indicate more sensitivity to reward. Change is defined as the average change in reward sensitivity from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC1.60

Change From Pre-intervention to Intervention Endpoint in Weekly Average Binge-eating Frequency

Binge eating frequency is based on a weekly diary of self-reported binge eating frequency. Participants were asked how many times during the past week they had a binge eating episode. Scores can range from 0 to infinity as frequency is self-reported as the number of binge eating episodes in the previous week. Higher scores indicate more episodes of binge eating. Change is defined as the average change in self-reported binge eating frequency from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionepisodes/week (Mean)
Continuous OC-0.43

Change From Pre-intervention to Intervention Endpoint in Dorsal Striatum Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Dorsal striatum reactivity (defined as caudate signal intensity and putamen signal intensity) to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
CaudatePutamen
Continuous OC-.012.02

Correlation Between Irritability and Reactive Aggression During Hormone Addback

"This outcome measure determines the degree of irritability and reactive aggression in HS+ during hormone addback and its relationship to the target population. Irritability will be defined as score on the IDAS Ill Temper Scale. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~The Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to ac" (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)0.18
Hormone Insensitive Women (HS-)0.03

Correlation Between Irritability Subcortical Activation in HS+ During Hormone Addback

"This outcome measure determines the degree of subcortical (amygdala, caudate, putamen, and nucleus accumbens) activation in HS+ during hormone addback and it's relationship to the target population. The activation in amygdala and ventral striatum (caudate, putamen, nucleus accumbens) regions of interest (ROIs) will be assessed during the Affective Posner Task.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)0.47

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill -0.8Scale and Threat Attention Bias

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper (i.e., irritability) Scale and threat attention bias. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)-0.35
Hormone Insensitive Women (HS-)0.11

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Left Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Mean)
Hormone Sensitive Women (HS+)-0.13
Hormone Insensitive Women (HS-)0.49

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Right Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)-0.57
Hormone Insensitive Women (HS-)-0.08

Mean BOLD Activation of the Left Amygdala During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)-0.009866667-0.086876444
Hormone Sensitive Women (HS+)0.005316917-0.047401917

Mean BOLD Activation of the Left Caudate During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0077258-0.049988
Hormone Sensitive Women (HS+)-0.0439433330.059099917

Mean BOLD Activation of the Left Nucleus Accumbens During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0691907-0.072512
Hormone Sensitive Women (HS+)-0.0284518180.031632727

Mean BOLD Activation of the Left Putamen During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0383029-0.021029
Hormone Sensitive Women (HS+)-0.0012234620.048155385

Mean BOLD Activation of the Right Amygdala During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.037334-0.15643
Hormone Sensitive Women (HS+)-0.045440.022654

Mean BOLD Activation of the Right Caudate During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0614070.0058011
Hormone Sensitive Women (HS+)-0.0699190770.045146154

Mean BOLD Activation of the Right Nucleus Accumbens During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.052685333-0.006394444
Hormone Sensitive Women (HS+)0.044384167-0.005181667

Mean BOLD Activation of the Right Putamen During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.002542222-0.080736333
Hormone Sensitive Women (HS+)-0.0075606920.036225385

Mean Left Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionarbitrary units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.02130.00111
Hormone Sensitive Women (HS+)0.0247-0.0192

Mean Reactive Aggression During Hormone Addback Over Time

"This outcome measure determines the extent to which HS+ is characterized by reactive aggression during hormone addback relative to baseline in the target population. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to accrue money or press another button to subtract money from a (fictional) partner at no direct gain to themselves. Frustration is induced by periodic subtractions of their own money, which is attributed to the partner." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionNumber of subtraction responses (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)129.2054.90
Hormone Sensitive Women (HS+)103.0834.62

Mean Right Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) Blood-oxygen-level-dependent (BOLD) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionarbitrary units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.05330.00804
Hormone Sensitive Women (HS+)0.0174-0.0114

Mean Threat Processing Bias During Visual Dot-probe Paradigm Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS- by examining threat attention bias assessed during the visual dot-probe paradigm.~The Visual Dot-Probe Paradigm asks participants to detect a target stimulus that is embedded in a matrix of distracting stimuli (e.g., a target stimulus, an angry face, might be embedded in a matrix of neutral distractor faces). Attention biases are inferred from faster response times to detect a threatening stimulus in a matrix of neutral stimuli relative to response time to detect neutral stimuli in neutral matrices. Thus, positive times reflect attention bias toward threat, whereas negative times reflect attention bias away from threat." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionattention bias in milliseconds (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)36.92-42.35
Hormone Sensitive Women (HS+)-0.57-9.04

Reviews

21 reviews available for estrone and Menopause

ArticleYear
CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review.
    American journal of epidemiology, 2004, Oct-15, Volume: 160, Issue:8

    Topics: 5' Untranslated Regions; Age Factors; Breast; Confounding Factors, Epidemiologic; Estradiol; Estroge

2004
Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Annals of the New York Academy of Sciences, 2005, Volume: 1052

    Topics: Administration, Cutaneous; Administration, Oral; Cognition; Estradiol; Estrogen Replacement Therapy;

2005
Aminoglutethimide in the treatment of advanced breast cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic;

1984
Steroid hormones, ageing and bone.
    Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:1

    Topics: Adult; Aged; Aging; Androstenedione; Bone and Bones; Calcium; Castration; Dehydroepiandrosterone; Es

1981
Ovarian failure and ageing.
    Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:1

    Topics: Administration, Oral; Aging; Androgens; Blood Coagulation Disorders; Castration; Climacteric; Drug I

1981
Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma.
    Acta endocrinologica. Supplementum, 1980, Volume: 233

    Topics: Adolescent; Adult; Aged; Animals; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female;

1980
Oestrogen therapy in the peri-menopause: A practical approach.
    Acta endocrinologica. Supplementum, 1980, Volume: 233

    Topics: Administration, Oral; Aged; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estr

1980
Age, estrogen, and the endometrium.
    Clinical obstetrics and gynecology, 1981, Volume: 24, Issue:1

    Topics: Androstenedione; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Progesterone

1981
The pituitary-gonadal function in postmenopausal women with epithelial ovarian tumors.
    APMIS. Supplementum, 1997, Volume: 74

    Topics: Animals; Biomarkers, Tumor; Blood Proteins; CA-125 Antigen; Epithelium; Estradiol; Estrone; Female;

1997
[Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (4)].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57 Suppl

    Topics: Adolescent; Adult; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Menstruation; O

1999
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
    Cancer, 1977, Volume: 39, Issue:6 Suppl

    Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy

1977
Estrogen and endometrial carcinoma.
    Obstetrical & gynecological survey, 1977, Volume: 32, Issue:5

    Topics: Androstenedione; Animals; Diethylstilbestrol; Estrogens; Estrone; Female; Humans; Luteinizing Hormon

1977
The role of hormones in the etiology of human breast cancer.
    Cancer, 1977, Volume: 39, Issue:6 Suppl

    Topics: 17-Ketosteroids; Androgens; Androsterone; Breast Neoplasms; Contraceptives, Oral, Hormonal; Estradio

1977
Estrogenic hormones -- general considerations.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1976, Volume: 54

    Topics: Animals; Carcinogens; Chemical Phenomena; Chemistry; Estradiol; Estradiol Congeners; Estriol; Estrog

1976
Hormonal dynamics associated with the menopause.
    Clinical obstetrics and gynecology, 1976, Volume: 19, Issue:4

    Topics: Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Gonadotropins, Pituitary; Humans;

1976
Post-menopausal estrogen production, with special reference to patients with mammary carcinoma.
    Frontiers of hormone research, 1975, Volume: 3

    Topics: Age Factors; Aged; Androgens; Androstenedione; Binding, Competitive; Body Weight; Breast Neoplasms;

1975
Estrone v estradiol: an examination of relative carcinogenic potential.
    International journal of fertility, 1986, Volume: 31, Issue:3 Suppl [E

    Topics: Aged; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Risk Factors; Uterine Neoplasms

1986
The saga of the ring B unsaturated equine estrogens.
    Endocrine reviews, 1988, Volume: 9, Issue:4

    Topics: Animals; Cholesterol; Equilin; Estradiol; Estrogens; Estrone; Female; Horses; Humans; Menopause; Pre

1988
Endocrine influences on human mammary cancer formation. A critique.
    Cancer, 1969, Volume: 23, Issue:4

    Topics: Adrenocorticotropic Hormone; Androgens; Androsterone; Animals; Binding Sites; Breast Diseases; Breas

1969
[Female gonadal gland].
    Horumon to rinsho. Clinical endocrinology, 1973, Volume: 21, Issue:1

    Topics: Adult; Aged; Aging; Androgens; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone;

1973
Current status of estrogen assay in gynecology and obstetrics. I. Estrogen assays in gynecology and early pregnancy.
    Obstetrical & gynecological survey, 1972, Volume: 27, Issue:4

    Topics: Abortion, Threatened; Chorionic Gonadotropin; Chromatography, Gas; Contraceptive Agents, Female; End

1972

Trials

60 trials available for estrone and Menopause

ArticleYear
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
    Maturitas, 2023, Volume: 167

    Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones

2023
Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis.
    Menopause (New York, N.Y.), 2017, Volume: 24, Issue:10

    Topics: Adult; Biomarkers; Cross-Sectional Studies; Estradiol; Estrone; Female; Glycogen; Hot Flashes; Human

2017
Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy.
    Menopause (New York, N.Y.), 2015, Volume: 22, Issue:12

    Topics: Administration, Oral; Adult; Aged; Biological Availability; Drug Combinations; Estradiol; Estrone; F

2015
Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:7

    Topics: Biomarkers, Tumor; Breast Neoplasms; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Est

2008
Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
    American journal of obstetrics and gynecology, 2003, Volume: 189, Issue:1

    Topics: Aged; Atrophy; Double-Blind Method; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Fema

2003
Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin').
    Lancet (London, England), 1980, Jan-05, Volume: 1, Issue:8158

    Topics: 17-Ketosteroids; Castration; Equilin; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Human

1980
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.
    Cancer research, 1982, Volume: 42, Issue:8 Suppl

    Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone;

1982
Aminoglutethimide dose and hormone suppression in advanced breast cancer.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:4

    Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sul

1983
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:4

    Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone

1984
Aminoglutethimide in the treatment of advanced breast cancer.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic;

1984
Is oestrogen therapy effective in the treatment of menopausal depression?
    The Journal of the Royal College of General Practitioners, 1981, Volume: 31, Issue:224

    Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Estrogens, Conjugated (USP); Estro

1981
The effect of type and dose of oestrogen on the blood pressure of post-menopausal women.
    Maturitas, 1983, Volume: 5, Issue:2

    Topics: Antihypertensive Agents; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Est

1983
The role of aromatase inhibitors in breast cancer.
    Seminars in oncology, 1983, Volume: 10, Issue:4 Suppl 4

    Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as

1983
[Percutaneous estrogen replacement therapy. An alternative for oral treatment].
    Duodecim; laaketieteellinen aikakauskirja, 1983, Volume: 99, Issue:20

    Topics: Estradiol; Estrone; Female; Humans; Lynestrenol; Menopause; Middle Aged; Skin Absorption

1983
Uptake and metabolism of oestriol in human target tissues.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:4B

    Topics: Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Myometrium; Subcel

1984
Steroid and gonadotropin profiles in menopausal women on three different oral replacement regimens.
    Annals of clinical research, 1980, Volume: 12, Issue:6

    Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Female

1980
Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
    Acta endocrinologica, 1982, Volume: 101, Issue:4

    Topics: Administration, Oral; Administration, Topical; Adult; Estradiol; Estrone; Female; Follicle Stimulati

1982
Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins.
    Journal of steroid biochemistry, 1980, Volume: 13, Issue:4

    Topics: Cell Nucleus; Cytosol; Endometrium; Estradiol; Estradiol Congeners; Estrone; Female; Humans; Menopau

1980
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
    Maturitas, 1994, Volume: 18, Issue:3

    Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Th

1994
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Aged; Aldosterone; Androstenedione; Aromatase In

1993
[The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women].
    Annales Academiae Medicae Stetinensis, 1997, Volume: 43

    Topics: 17-alpha-Hydroxyprogesterone; Abortion, Spontaneous; Adult; Carbon Disulfide; Chemical Industry; Dop

1997
Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
    Therapeutic drug monitoring, 2001, Volume: 23, Issue:2

    Topics: Administration, Topical; Adult; Aged; Double-Blind Method; Estradiol; Estrone; Female; Gels; Humans;

2001
Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2002, Volume: 17, Issue:1

    Topics: Aged; Aromatase Inhibitors; Bone Remodeling; Bone Resorption; Double-Blind Method; Enzyme Inhibitors

2002
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
    Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3

    Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Femal

1998
Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Annals of clinical research, 1979, Volume: 11, Issue:5

    Topics: Climacteric; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; E

1979
Efficacy of estradiol vaginal cream in postmenopausal women.
    Clinical pharmacology and therapeutics, 1979, Volume: 26, Issue:4

    Topics: Administration, Topical; Aged; Dosage Forms; Double-Blind Method; Estradiol; Estrogens, Conjugated (

1979
Experimental and clinical data on Cyclabil.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1977, Volume: 65

    Topics: Adult; Cervix Mucus; Cervix Uteri; Clinical Trials as Topic; Drug Combinations; Estradiol; Estrone;

1977
Letter: Natural oestrogen replacement therapy and blood clotting.
    British medical journal, 1976, Jan-24, Volume: 1, Issue:6003

    Topics: Blood Coagulation; Clinical Trials as Topic; Estrone; Ethinyl Estradiol; Female; Humans; Menopause

1976
Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory.
    Current medical research and opinion, 1976, Volume: 4, Issue:4

    Topics: Adult; Aged; Clinical Trials as Topic; Estrone; Female; Humans; Memory; Menopause; Middle Aged; Pipe

1976
Double blind study on the effect of estrogen on sleep, anxiety and depression in perimenopausal women: preliminary results.
    Proceedings of the Royal Society of Medicine, 1976, Volume: 69, Issue:11

    Topics: Anxiety; Climacteric; Clinical Trials as Topic; Depression; Estrone; Female; Humans; Menopause; Midd

1976
Postmenopausal symptomatology, maturation index, and plasma estrogen levels.
    Obstetrics and gynecology, 1975, Volume: 45, Issue:6

    Topics: Adult; Aged; Castration; Clinical Trials as Topic; Estradiol; Estradiol Congeners; Estrogens; Estron

1975
Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
    Maturitas, 1992, Volume: 15, Issue:2

    Topics: Administration, Intravaginal; Aged; Atrophy; Double-Blind Method; Epithelium; Estradiol; Estrone; Fe

1992
Effects of estrogen on memory function in surgically menopausal women.
    Psychoneuroendocrinology, 1992, Volume: 17, Issue:5

    Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Hysterectomy; Menopau

1992
A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy.
    American journal of obstetrics and gynecology, 1992, Volume: 167, Issue:2

    Topics: Adult; Aged; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Menopause; Middle Age

1992
Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women.
    Journal of clinical pharmacology, 1991, Volume: 31, Issue:6

    Topics: Blood Pressure; Drug Therapy, Combination; Estradiol; Estrogens, Conjugated (USP); Estrone; Female;

1991
Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women.
    Maturitas, 1991, Volume: 13, Issue:4

    Topics: Administration, Cutaneous; Adult; Alkaline Phosphatase; Body Temperature; Bone Density; Calcium; Est

1991
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:1

    Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormo

1991
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
    Journal of gerontology, 1991, Volume: 46, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index;

1991
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:2

    Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medrox

1991
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
    Maturitas, 1990, Volume: 12, Issue:4

    Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; L

1990
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.
    Clinical endocrinology, 1990, Volume: 32, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug;

1990
Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women.
    Biological psychiatry, 1990, Aug-15, Volume: 28, Issue:4

    Topics: Affect; Blood Platelets; Carrier Proteins; Estradiol; Estrogen Replacement Therapy; Estrone; Female;

1990
Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels.
    Obstetrics and gynecology, 1990, Volume: 76, Issue:1

    Topics: Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estrone; Female; Humans; Hypercholesterolem

1990
The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
    American journal of epidemiology, 1990, Volume: 132, Issue:5

    Topics: Androstenedione; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Estradiol; Estrone; Female;

1990
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
    Maturitas, 1989, Volume: 11, Issue:2

    Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; F

1989
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
    Maturitas, 1989, Volume: 11, Issue:2

    Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP);

1989
Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1989, Volume: 29, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Double-Blind Method; Estradiol; Estrogen Replacemen

1989
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation;

1989
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
    Cancer research, 1989, Mar-01, Volume: 49, Issue:5

    Topics: Administration, Oral; Androstenedione; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol

1989
Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
    American journal of obstetrics and gynecology, 1988, Volume: 159, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Bone and Bones; Cholesterol, HDL; Cholestero

1988
Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.
    British journal of obstetrics and gynaecology, 1987, Volume: 94, Issue:6

    Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Estradiol Congeners; Estrone; Female; Follicle

1987
Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapy.
    Gynecologic and obstetric investigation, 1988, Volume: 25, Issue:1

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Clinical Trials as Topic; Double-Blind Method; Dr

1988
The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
    Circulation, 1987, Volume: 76, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Blood Pressure; Clinical Trials as Topic; Estradiol

1987
Effect of low- and high-fat intakes on the hormonal milieu of premenopausal women.
    The American journal of clinical nutrition, 1988, Volume: 47, Issue:4

    Topics: Adult; Dietary Fats; Energy Intake; Estradiol; Estrogens; Estrone; Female; Hormones; Humans; Luteini

1988
Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women.
    Maturitas, 1986, Volume: 8, Issue:3

    Topics: Adult; Body Composition; Body Weight; Creatinine; Drug Therapy, Combination; Estradiol; Estrogens; E

1986
Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.
    American journal of obstetrics and gynecology, 1985, Jan-15, Volume: 151, Issue:2

    Topics: Adult; Androgens; Appetite; Castration; Clinical Trials as Topic; Double-Blind Method; Drug Therapy,

1985
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    The New England journal of medicine, 1985, Oct-17, Volume: 313, Issue:16

    Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; M

1985
The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina.
    Annales chirurgiae et gynaecologiae Fenniae, 1974, Volume: 63, Issue:3

    Topics: Aged; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause

1974
An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
    Current medical research and opinion, 1974, Volume: 2, Issue:7

    Topics: Adult; Amenorrhea; Atrophy; Clinical Trials as Topic; Estradiol Congeners; Estrogens; Estrogens, Con

1974
A clinical trial of piperazine oestrone sulphate ('Harmogen') in the treatment of menopausal symptoms.
    Current medical research and opinion, 1974, Volume: 2, Issue:5

    Topics: Adult; Estradiol; Estrone; Female; Humans; Hysterectomy; Menopause; Middle Aged; Piperazines; Placeb

1974

Other Studies

498 other studies available for estrone and Menopause

ArticleYear
Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.
    Maturitas, 2012, Volume: 72, Issue:1

    Topics: Adipose Tissue; Aged; Aged, 80 and over; Body Composition; Body Fluid Compartments; Calcium, Dietary

2012
Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand.
    Acta endocrinologica, 1983, Volume: 103, Issue:2

    Topics: Adult; Aged; Cross Reactions; Estrone; Female; Fetal Blood; Humans; Hydroxyestrones; Infant, Newborn

1983
Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:2

    Topics: Estrone; Female; Follicle Stimulating Hormone; Humans; Hydroxyestrones; Kinetics; Luteinizing Hormon

1980
A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Environmental health perspectives, 1997, Volume: 105 Suppl 3

    Topics: Breast Neoplasms; Case-Control Studies; Estradiol; Estriol; Estrone; Female; Humans; Hydroxyestrones

1997
Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.
    Environmental health perspectives, 1997, Volume: 105 Suppl 3

    Topics: Adult; Biomarkers; Breast Neoplasms; Estrogens; Evaluation Studies as Topic; Female; Follicular Phas

1997
Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
    Annals of the Academy of Medicine, Singapore, 1998, Volume: 27, Issue:2

    Topics: Age Factors; Anticarcinogenic Agents; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Cell Tra

1998
The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment.
    Steroids, 1999, Volume: 64, Issue:3

    Topics: Adult; Circadian Rhythm; Female; Humans; Hydroxyestrones; Menopause; Menstrual Cycle; Risk Assessmen

1999
Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking.
    The New England journal of medicine, 1986, Nov-20, Volume: 315, Issue:21

    Topics: Adult; Estradiol; Estrogens; Female; Humans; Hydroxyestrones; Hydroxylation; Menopause; Menstrual Cy

1986
Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition.
    BMC women's health, 2023, 05-25, Volume: 23, Issue:1

    Topics: Androgens; Androstenedione; Cross-Sectional Studies; Estradiol; Estrone; Female; Follicle Stimulatin

2023
Within-person changes in reproductive hormones and cognition in the menopause transition.
    Maturitas, 2023, Volume: 177

    Topics: Cognition; Estradiol; Estrone; Executive Function; Female; Humans; Menopause

2023
Variation of urinary follicle-stimulating hormone level after menopause : From the results of Japan Nurses' Health Study.
    The journal of medical investigation : JMI, 2019, Volume: 66, Issue:3.4

    Topics: Body Mass Index; Cross-Sectional Studies; Estradiol; Estrone; Female; Follicle Stimulating Hormone;

2019
Simultaneous analysis of E1 and E2 by LC-MS/MS in healthy volunteers: estimation of reference intervals and comparison with a conventional E2 immunoassay.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021, Jul-15, Volume: 1178

    Topics: Adolescent; Adult; Chromatography, Liquid; Estradiol; Estrone; Female; Humans; Immunoassay; Limit of

2021
Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
    The Journal of clinical endocrinology and metabolism, 2018, 08-01, Volume: 103, Issue:8

    Topics: Adult; Asymptomatic Diseases; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickne

2018
SULESTREX.
    What's new, 1952, Volume: 164

    Topics: Climacteric; Estrogens; Estrone; Female; Menopause

1952
EFFECTIVE estrogenic therapy with sulestrex. . . for menopause and suppression of lactation.
    What's new, 1952, Volume: 60

    Topics: Climacteric; Estrogens; Estrone; Female; Humans; Lactation; Menopause

1952
Immunologic and mass-spectrometric estimates of SHBG concentrations in healthy women.
    Metabolism: clinical and experimental, 2014, Volume: 63, Issue:6

    Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol, HDL; Estradiol; Estrone; Female; Humans; I

2014
Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:6

    Topics: Adult; Affective Symptoms; Autonomic Nervous System; Cognition Disorders; Estrone; Female; Follicle

2014
Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery.
    Journal of obesity, 2014, Volume: 2014

    Topics: Adult; Age Factors; Aged; Animals; Apolipoproteins; Bariatric Surgery; Cholesterol, LDL; Complement

2014
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
    Steroids, 2015, Volume: 99, Issue:Pt A

    Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition

2015
Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol.
    Microscopy research and technique, 2017, Volume: 80, Issue:7

    Topics: Adolescent; Adult; Estriol; Estrone; Female; Fibrin; Fibrinolysis; Humans; Male; Menopause; Pregnanc

2017
THEELIN in menopause.
    Therapeutic notes, 1948, Volume: 55, Issue:4

    Topics: Estrone; Female; Humans; Menopause

1948
Meprane in the treatment of the menopausal syndrome; an evaluation of estrogenic efficiency and toxicity.
    American journal of obstetrics and gynecology, 1948, Volume: 56, Issue:3

    Topics: Estrone; Female; Humans; Menopause; Syndrome

1948
Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female twin pairs.
    Journal of applied physiology (Bethesda, Md. : 1985), 2009, Volume: 106, Issue:4

    Topics: Achilles Tendon; Aged; Cholesterol; Estrogens; Estrone; Female; Hormone Replacement Therapy; Humans;

2009
Total and unopposed estrogen exposure across stages of the transition to menopause.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:3

    Topics: Adult; Algorithms; Estrone; Female; Humans; Menopause; Middle Aged; Pregnanediol; Time Factors

2009
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
    The Journal of steroid biochemistry and molecular biology, 2009, Volume: 117, Issue:1-3

    Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopa

2009
Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
    Journal of women's health (2002), 2010, Volume: 19, Issue:2

    Topics: Aged; Estrone; Female; Follicle Stimulating Hormone; Health Services Research; Humans; Libido; Menop

2010
Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:3

    Topics: Adrenal Glands; Animals; Atrophy; Drugs, Chinese Herbal; Estradiol; Estrone; Female; Gonadal Steroid

2010
THEELIN therapy of menopause.
    Therapeutic notes, 1946

    Topics: Estrone; Female; Humans; Menopause

1946
[Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (E4)].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68 Suppl 7

    Topics: Adolescent; Adult; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Menstruation; O

2010
THEELIN therapy of menopause.
    Therapeutic notes, 1945, Volume: 52

    Topics: Estrone; Female; Humans; Menopause

1945
Effects of unintentional exposure of children to compounded transdermal sex hormone therapy.
    Pediatric endocrinology reviews : PER, 2011, Volume: 8, Issue:3

    Topics: Administration, Cutaneous; Age Determination by Skeleton; Child, Preschool; Drug Compounding; Estrad

2011
Cognitive symptoms during the menopausal transition and early postmenopause.
    Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:2

    Topics: Adult; Attention; Cognition Disorders; Estrone; Female; Health Status; Humans; Hydrocortisone; Longi

2011
Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat.
    Hormones and behavior, 2012, Volume: 62, Issue:1

    Topics: Animals; Cholinergic Neurons; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjuga

2012
Doubts about oestrogen therapy in postmenopausal women.
    Research in reproduction, 1976, Volume: 8, Issue:1

    Topics: Age Factors; Biology; Birth Rate; Contraception; Contraceptive Agents; Contraceptive Agents, Female;

1976
Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
    Contraceptive delivery systems, 1983, Volume: 4, Issue:1

    Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Endome

1983
[Estrogenic function in the menopause].
    Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie, 1954, Volume: 137, Issue:4

    Topics: Climacteric; Estradiol Congeners; Estrogens; Estrone; Female; Humans; Menopause; Ovary

1954
[The cytological picture of estrogenic action during the climacteric].
    Revista del Instituto Nacional de Cancerologia, 1961, Volume: 3

    Topics: Climacteric; Estrone; Female; Humans; Menopause; Ovary; Vaginal Smears

1961
[Estrogenic hormones in men: the chromatographic separation of urinary estriol, estrone and estradiol in normal adults and subjects in the climacteric].
    Folia endocrinologica; mensile di incretologia e incretoterapia, 1962, Volume: 15

    Topics: Chromatography; Climacteric; Estradiol; Estriol; Estrone; Humans; Menopause; Urinary Tract

1962
ESTROGEN METABOLISM IN POSTMENAPAUSAL WOMEN WITH GENITAL CANCER.
    Annales chirurgiae et gynaecologiae Fenniae, 1963, Volume: 52

    Topics: Body Fluids; Estradiol; Estriol; Estrogens; Estrone; Female; Genital Neoplasms, Female; Humans; Lipi

1963
THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. I. EXCRETION AFTER SPONTANEOUS MENOPAUSE.
    Acta endocrinologica, 1963, Volume: 44

    Topics: Breast Neoplasms; Estrone; Geriatrics; Humans; Menopause; Pregnanediol; Pregnanetriol; Urine

1963
ABDOMINOVAGINAL POTENTIAL DIFFERENCE IN POSTMENOPAUSAL PATIENTS WITH AND WITHOUT BREAST CANCER.
    Cancer, 1964, Volume: 17

    Topics: Abdominal Wall; Adolescent; Androgens; Breast Neoplasms; Castration; Climacteric; Electrophysiology;

1964
[ISOLATION OF ESTRONE, 17-BETA ESTRADIOL AND AN UNUSUAL LARGE QUANTITY OF ESTRIOL FROM THE URINE OF A PATIENT WITH OVARIAN CANCER].
    Orvosi hetilap, 1964, Jan-26, Volume: 105

    Topics: Body Fluids; Chromatography; Estradiol; Estriol; Estrone; Female; Granulosa Cell Tumor; Humans; Meno

1964
[STUDY ON THE BIOLOGICAL ACTIVITY OF THE ESTRIOL EPIMERS 16-EPIOESTRIOL, 17-EPIOESTRIOL AND 16,17-EPIOESTRIOL].
    Acta endocrinologica, 1964, Volume: 45

    Topics: 17-Ketosteroids; Animals; Ergotamine; Estradiol; Estriol; Estrone; Female; Gonadotropins; Gonadotrop

1964
"PROPHYLACTIC" OVARIECTOMY AND OVARIAN IRRADIATION IN BREAST CANCER.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Breast Neoplasms; Castration; Estrone; Female; Humans; Mastectomy; Menopause; Neoplasms; Ovariectomy

1964
ENDOCRINE TREATMENT OF BREAST CANCER.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Anabolic Agents; Androgens; Breast Neoplasms; Castration; Estrone; Female; Humans; Menopause; Nandro

1964
HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL.
    Science (New York, N.Y.), 1964, Aug-14, Volume: 145, Issue:3633

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androsterone; Breast Neoplasms; Creatine; Creatinine

1964
[ROLE OF HORMONAL FACTORS IN THE PATHOGENESIS OF HYPERCHOLESTEREMIA AND ATHEROSCLEROSIS. EFFECT OF ESTROGENS ON LIPID METABOLISM AND ON THE DEVELOPMENT OF ATHEROSCLEROSIS].
    Terapevticheskii arkhiv, 1964, Volume: 36

    Topics: Arteriosclerosis; Atherosclerosis; Biomedical Research; Chorionic Gonadotropin; Estradiol; Estriol;

1964
VAGINAL ELECTRO POTENTIALS--A NEW TECHNIQUE FOR ASSESSING THE ESTROGENIC STATUS OF PATIENTS.
    Surgical forum, 1964, Volume: 15

    Topics: Diagnosis; Electrophysiology; Estradiol Congeners; Estrogens; Estrone; Female; Gynecology; Humans; M

1964
OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER.
    Acta endocrinologica, 1964, Volume: 47

    Topics: 17-Hydroxycorticosteroids; Breast Neoplasms; Castration; Cortisone; Estradiol; Estriol; Estrogens; E

1964
ENDOCRINE RELATIONSHIPS OF LEUKOCYTE ALKALINE PHOSPHATASE.
    Blood, 1965, Volume: 25

    Topics: Alkaline Phosphatase; Androgens; Breast Neoplasms; Castration; Child; Enzyme Inhibitors; Estradiol;

1965
THE EXCRETION OF OESTROGENS AND PREGNANEDIOL IN PATIENTS WITH MAMMARY CARCINOMA.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Breast Neoplasms; Drug Therapy; Estradiol; Estriol; Estrogens; Estrone; Female; Fluids and Secretion

1964
II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.
    American journal of obstetrics and gynecology, 1965, Jun-15, Volume: 92

    Topics: Breast Diseases; Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Estriol; Estrogens; Estr

1965
Estrone sulfate soluble in the treatment of estrogen deficiency.
    American journal of obstetrics and gynecology, 1952, Volume: 63, Issue:6

    Topics: Climacteric; Estrogens; Estrone; Female; Humans; Menopause

1952
Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:6

    Topics: Adult; Age Distribution; Asian People; Black People; Body Constitution; Cohort Studies; Corpus Luteu

2004
[Simplification of cytological diagnosis of uterine cancer during the menopause by Papanicolaou's and Traut's method of preliminary folliculin treatment].
    Zentralblatt fur Gynakologie, 1950, Volume: 72, Issue:5

    Topics: Climacteric; Estrogens; Estrone; Female; Humans; Menopause; Neoplasms; Uterine Neoplasms; Uterus

1950
Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women.
    Breast (Edinburgh, Scotland), 2006, Volume: 15, Issue:1

    Topics: Adult; Body Weight; Breast Neoplasms; Cross-Sectional Studies; Estradiol; Estrone; Female; Hormone R

2006
Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status.
    Journal of medical primatology, 2005, Volume: 34, Issue:4

    Topics: Androstenedione; Animals; Blood Glucose; C-Peptide; Carbohydrates; Dehydroepiandrosterone Sulfate; E

2005
Cigarette smoking, estrogen levels, and hot flashes in midlife women.
    Maturitas, 2006, Jan-20, Volume: 53, Issue:2

    Topics: Baltimore; Body Mass Index; Case-Control Studies; Chi-Square Distribution; Educational Status; Estra

2006
Bio-identical steroid hormone replacement: selected observations from 23 years of clinical and laboratory practice.
    Annals of the New York Academy of Sciences, 2005, Volume: 1057

    Topics: Cobalt; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrone; Female; Humans; Menopause; Mens

2005
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:5

    Topics: Adult; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Co

2006
Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
    Maturitas, 2006, Aug-20, Volume: 55, Issue:1

    Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Androstenedione; Body Composition; Cross-Sectional Stu

2006
Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy?: a critical appraisal of cardiovascular risks in menopausal women.
    Treatments in endocrinology, 2006, Volume: 5, Issue:6

    Topics: Cardiovascular Diseases; Estriol; Estrogen Replacement Therapy; Estrone; Female; Hormone Replacement

2006
Characterizing daily urinary hormone profiles for women at midlife using functional data analysis.
    American journal of epidemiology, 2007, Apr-15, Volume: 165, Issue:8

    Topics: Adult; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menstr

2007
Synthesis of highly tritium labeled steroids for evaluation of aromatase and steroidsulfatase activities in endometrial tumors.
    Bulletin of experimental biology and medicine, 2006, Volume: 142, Issue:4

    Topics: Aromatase; Cell Differentiation; Endometrial Neoplasms; Estrone; Female; Humans; Isotope Labeling; M

2006
Hot flash severity in hormone therapy users/nonusers across the menopausal transition.
    Maturitas, 2007, Oct-20, Volume: 58, Issue:2

    Topics: Adult; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone, Human; Hot Flash

2007
The effects of various estrogenic preparations; changes in the vaginal mucosa and general status of climacteric women following the injection of aqueous suspensions of estrone and estradiol.
    American journal of obstetrics and gynecology, 1949, Volume: 57, Issue:4

    Topics: Climacteric; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Mucous Membrane; Suspensions;

1949
Factors related to declining luteal function in women during the menopausal transition.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:5

    Topics: Adult; Asian People; Body Mass Index; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteal

2008
HDL-cholesterol and sex-hormone status.
    Lancet (London, England), 1980, Jan-26, Volume: 1, Issue:8161

    Topics: Age Factors; Aged; Cholesterol; Estradiol; Estrone; Female; Humans; Lipoproteins, HDL; Menopause; Mi

1980
Pituitary-ovarian hormones after low-dose endometrial afterloading irradiation.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1981, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Age Factors; Amenorrhea; Endometrium; Estradiol; Estrone; Female; Follicle Stimul

1981
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1982, Volume: 20, Issue:2

    Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conj

1982
Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1982, Volume: 20, Issue:5

    Topics: Adult; Drug Implants; Drug Therapy, Combination; Estradiol; Estrogens; Estrone; Female; Follicle Sti

1982
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1983, Volume: 21, Issue:4

    Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combine

1983
Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
    Acta chirurgica Scandinavica, 1982, Volume: 148, Issue:4

    Topics: Adrenal Cortex Hormones; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estrone; Fe

1982
Serum levels of cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulphate, estrone and prolactin after surgical trauma in postmenopausal women.
    Upsala journal of medical sciences, 1982, Volume: 87, Issue:3

    Topics: Adrenal Cortex Hormones; Aged; Cholecystectomy; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfa

1982
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
    British journal of cancer, 1983, Volume: 47, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cos

1983
Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
    European journal of gynaecological oncology, 1983, Volume: 4, Issue:2

    Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Endometrial Hyperplasia; Estradiol; Estro

1983
Peripheral hormone levels and the endometrial condition in postmenopausal women.
    Acta obstetricia et gynecologica Scandinavica, 1983, Volume: 62, Issue:5

    Topics: Body Weight; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrium; Estradiol; Estroge

1983
Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Androstenediol; Androstenediols; Brea

1984
The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
    British journal of obstetrics and gynaecology, 1980, Volume: 87, Issue:7

    Topics: Cholesterol; Drug Combinations; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female;

1980
Radioimmunoassay of plasma equilin and estrone in postmenopausal women after the administration of premarin.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 52, Issue:4

    Topics: 17-Ketosteroids; Equilin; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Kinetics;

1981
The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins.
    Journal of steroid biochemistry, 1981, Volume: 14, Issue:3

    Topics: 17-Hydroxysteroid Dehydrogenases; DNA; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens,

1981
Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
    Clinical endocrinology, 1980, Volume: 13, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Castration; Dehydroepiandrosterone; Estradiol; Estrogens; Estr

1980
A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy.
    Maturitas, 1980, Volume: 2, Issue:4

    Topics: Aged; Atrophy; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone

1980
Adrenal steroids, bone mineral content and endometrial pathology in postmenopausal women.
    Acta obstetricia et gynecologica Scandinavica, 1981, Volume: 60, Issue:3

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bone and Bones; Dehydroepiandrosterone; Dehydr

1981
Systemic absorption of conjugated estrogenic cream by the irradiated vagina.
    Gynecologic oncology, 1981, Volume: 12, Issue:1

    Topics: Administration, Topical; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulati

1981
Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal women.
    Maturitas, 1981, Volume: 3, Issue:3-4

    Topics: Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Respo

1981
Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens.
    Maturitas, 1981, Volume: 3, Issue:3-4

    Topics: Age Factors; Emepronium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans;

1981
Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein.
    Acta obstetricia et gynecologica Scandinavica, 1982, Volume: 61, Issue:1

    Topics: Climacteric; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol;

1982
Adrenocortical steroids, bone mineral content and endometrial condition in post-menopausal women.
    Maturitas, 1982, Volume: 4, Issue:2

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bone and Bones; Dehydroepiandrosterone; Estron

1982
Comparison of pharmacodynamic properties of various estrogen formulations.
    American journal of obstetrics and gynecology, 1982, Nov-01, Volume: 144, Issue:5

    Topics: Angiotensinogen; Diethylstilbestrol; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Eth

1982
Differential clinical response to oestrogens after menopause.
    The Medical journal of Australia, 1982, Oct-02, Volume: 2, Issue:7

    Topics: Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause

1982
Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.
    Steroids, 1982, Volume: 39, Issue:5

    Topics: Adrenalectomy; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Estrogens, Conjugated (USP); Estron

1982
Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women.
    Acta endocrinologica, 1983, Volume: 102, Issue:1

    Topics: Climacteric; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Hu

1983
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:1

    Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol;

1983
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:1

    Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol;

1983
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:1

    Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol;

1983
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:1

    Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol;

1983
Behaviour of some steroids in postmenopausal women with coelomic ovarian tumors.
    European journal of gynaecological oncology, 1983, Volume: 4, Issue:3

    Topics: Adenocarcinoma, Mucinous; Androstenedione; Carcinoma; Dehydroepiandrosterone; Dehydroepiandrosterone

1983
The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue.
    Clinical endocrinology, 1983, Volume: 19, Issue:6

    Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adenofibroma; Adult; Aged; Breast; Breast Neoplasm

1983
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Obstetrics and gynecology, 1984, Volume: 63, Issue:1

    Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Est

1984
Estrone sulfate, estrone and estradiol concentrations in normal and cirrhotic postmenopausal women.
    Steroids, 1983, Volume: 41, Issue:5

    Topics: Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Liver Cirrhosis; Menopause; Radioim

1983
Estrogen replacement therapy by transdermal estradiol administration.
    American journal of obstetrics and gynecology, 1983, Jul-01, Volume: 146, Issue:5

    Topics: Calcium; Climacteric; Creatinine; Double-Blind Method; Estradiol; Estrone; Female; Follicle Stimulat

1983
Profiles and endocrine correlations in endometrial carcinoma.
    European journal of gynaecological oncology, 1983, Volume: 4, Issue:1

    Topics: Age Factors; Aged; Androstenedione; Diabetes Complications; Estradiol; Estrone; Female; Follicle Sti

1983
Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women.
    European journal of obstetrics, gynecology, and reproductive biology, 1983, Volume: 15, Issue:2

    Topics: Adult; Androstenedione; Climacteric; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid

1983
[Clinical effects of metharmon F for postmenopausal women with climacteric symptoms: its relationship with serum level of hormones].
    Horumon to rinsho. Clinical endocrinology, 1983, Volume: 31, Issue:8

    Topics: Androstenediol; Androstenediols; Androstenedione; Climacteric; Drug Combinations; Estrogens; Estrone

1983
Gonadotropins, estrogens, and adrenal steroids during the menopausal hot flash.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:4

    Topics: Androstenedione; Body Temperature; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stim

1980
Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects.
    Acta obstetricia et gynecologica Scandinavica, 1981, Volume: 60, Issue:1

    Topics: Adult; Climacteric; Dehydroepiandrosterone; Estrogens; Estrone; Female; Follicle Stimulating Hormone

1981
Oestrogens, the menopause and the adrenopause.
    The Journal of endocrinology, 1981, Volume: 89 Suppl

    Topics: Adrenal Glands; Adult; Age Factors; Androgens; Androstenedione; Castration; Dehydroepiandrosterone;

1981
How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
    The Journal of clinical endocrinology and metabolism, 1982, Volume: 54, Issue:1

    Topics: Adrenalectomy; Aged; Aldosterone; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrostero

1982
Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
    Maturitas, 1984, Volume: 6, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Hum

1984
The endogenous concentration of estradiol and estrone in normal human postmenopausal endometrium.
    Journal of steroid biochemistry, 1984, Volume: 21, Issue:5

    Topics: Aged; DNA; Endometrium; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Reference Values

1984
Androgen and estrogen dynamics in women with vertebral crush fractures.
    Maturitas, 1984, Volume: 6, Issue:4

    Topics: Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Female; Fractures, B

1984
Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone.
    The New England journal of medicine, 1984, Feb-23, Volume: 310, Issue:8

    Topics: Administration, Topical; Adult; Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Es

1984
Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
    Cancer research, 1984, Volume: 44, Issue:2

    Topics: Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Progesterone; Receptor

1984
Metabolism of estrone sulfate in human endometrium.
    Acta obstetricia et gynecologica Scandinavica, 1983, Volume: 62, Issue:5

    Topics: Aged; Endometrium; Estradiol; Estrone; Female; Humans; Hydrolysis; Menopause; Middle Aged; Progester

1983
Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer.
    American journal of obstetrics and gynecology, 1983, Mar-01, Volume: 145, Issue:5

    Topics: Aged; Androstenedione; Body Weight; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Hip Fractu

1983
Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
    Cancer research, 1983, Volume: 43, Issue:8

    Topics: Aged; Body Weight; Breast Diseases; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex

1983
Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
    Archives of gynecology, 1983, Volume: 233, Issue:2

    Topics: Adult; Androstenedione; Climacteric; Estradiol; Estriol; Estrone; Female; Gonadotropins; Humans; Men

1983
Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer.
    Cancer, 1984, Jun-15, Volume: 53, Issue:12

    Topics: Aged; Body Weight; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Time Factors;

1984
Variation in the fractional conversion of plasma estrone to estriol among women and men.
    The Journal of clinical endocrinology and metabolism, 1984, Volume: 58, Issue:6

    Topics: Adult; Aging; Biotransformation; Estriol; Estrone; Female; Humans; Male; Menopause; Middle Aged; Par

1984
Estriol production and metabolism in normal women.
    Journal of steroid biochemistry, 1984, Volume: 20, Issue:4B

    Topics: Adult; Estradiol; Estriol; Estrone; Female; Follicular Phase; Half-Life; Humans; Luteal Phase; Menop

1984
Hormonal profile of endometrial cancer.
    Gynecologic and obstetric investigation, 1984, Volume: 17, Issue:5

    Topics: Adult; Aged; Castration; Estradiol; Estrone; Female; Humans; Hysterectomy; Infertility, Female; Meno

1984
Plasma androstenedione and oestrone levels in the climacteric syndrome.
    Maturitas, 1984, Volume: 5, Issue:4

    Topics: Aged; Androstenedione; Estrone; Female; Humans; Menopause; Middle Aged; Plasma; Radioimmunoassay

1984
Metabolic clearance rate of oestrone sulphate in post-menopausal women.
    Maturitas, 1984, Volume: 5, Issue:4

    Topics: Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged

1984
Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
    American journal of obstetrics and gynecology, 1984, Jul-01, Volume: 149, Issue:5

    Topics: Adult; Age Factors; Aged; Central Nervous System; Dopamine; Estradiol; Estrogens; Estrone; Female; H

1984
[Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach].
    Nihon Sanka Fujinka Gakkai zasshi, 1984, Volume: 36, Issue:6

    Topics: Adult; Aged; Cytodiagnosis; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged

1984
The significance of oestriol in the management of the post-menopause.
    Acta endocrinologica. Supplementum, 1980, Volume: 233

    Topics: Aged; Cervix Mucus; Endometrium; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone;

1980
Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Acta obstetricia et gynecologica Scandinavica, 1980, Volume: 59, Issue:2

    Topics: Administration, Oral; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Kinetics; Lu

1980
Plasma hormones in pre- and postmenopausal breast cancer.
    Journal of steroid biochemistry, 1980, Volume: 13, Issue:7

    Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cortisone; Estradiol; Estrone; Female; Follicle Stimulat

1980
Absorption of percutaneous oestradiol in postmenopausal women.
    Maturitas, 1980, Volume: 2, Issue:3

    Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gels; Humans; Luteinizing Hormone; Menopau

1980
[Estrone, estradiol and estriol content after intravaginal application of estriol in postmenopause].
    Gynakologische Rundschau, 1980, Volume: 20 Suppl 1

    Topics: Aged; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone

1980
Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
    British journal of obstetrics and gynaecology, 1981, Volume: 88, Issue:4

    Topics: Adult; Castration; Drug Combinations; Drug Implants; Estradiol; Estrone; Female; Follicle Stimulatin

1981
Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
    Archives of gynecology, 1981, Volume: 230, Issue:3

    Topics: Adenocarcinoma; Aged; Castration; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortis

1981
Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
    Maturitas, 1981, Volume: 3, Issue:1

    Topics: Absorption; Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gona

1981
The absorption and metabolism of oral oestradiol, oestrone and oestriol.
    British journal of obstetrics and gynaecology, 1981, Volume: 88, Issue:8

    Topics: Adult; Estradiol; Estriol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Glucuronates; H

1981
Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
    Maturitas, 1981, Volume: 3, Issue:2

    Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Ra

1981
Gonadotropins and prolactin during estrogen replacement therapy.
    Acta obstetricia et gynecologica Scandinavica, 1981, Volume: 60, Issue:5

    Topics: Adult; Estradiol; Estriol; Estrogens; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormo

1981
Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    International journal of tissue reactions, 1981, Volume: 3, Issue:2

    Topics: Aged; Dose-Response Relationship, Drug; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating

1981
Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma.
    Maturitas, 1981, Volume: 3, Issue:3-4

    Topics: Adult; Aged; Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Hu

1981
Serum concentrations of FSH, oestradiol, oestrone and androstenedione in normal and obese women.
    Maturitas, 1982, Volume: 4, Issue:1

    Topics: Adult; Aged; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; Follicle Stimulati

1982
Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
    Acta endocrinologica, 1982, Volume: 101, Issue:1

    Topics: Absorption; Aged; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Horm

1982
Effect of the plasma estrone/17 beta-estradiol ratio on the prolactin and TSH responses to TRH.
    Neuroendocrinology, 1982, Volume: 35, Issue:3

    Topics: Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Rele

1982
Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
    Journal of steroid biochemistry, 1983, Volume: 18, Issue:4

    Topics: Adenocarcinoma; Breast; Breast Neoplasms; Cytosol; Estradiol; Estrone; Female; Humans; Kinetics; Men

1983
Obesity, serum cholesterol, and estrogens in premenopausal women.
    Oncology, 1983, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Aging; Body Weight; Cholesterol; Estradiol; Estriol; Estrogens; Estrone; Female;

1983
Estrone sulfate concentrations in plasma of normal individuals, postmenopausal women with breast cancer, and men with cirrhosis.
    Clinical chemistry, 1983, Volume: 29, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Chromatography; Estrone; Female; Humans; Liver Cirrhosis; Male; Menop

1983
Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
    Acta obstetricia et gynecologica Scandinavica, 1983, Volume: 62, Issue:1

    Topics: Administration, Topical; Estradiol; Estrone; Female; Gonadotropins; Hormones; Humans; Menopause; Mid

1983
The pharmacology of progestogens.
    The Journal of reproductive medicine, 1982, Volume: 27, Issue:8 Suppl

    Topics: Animals; Chemical Phenomena; Chemistry; Estrogen Antagonists; Estrone; Female; Humans; Lipoproteins,

1982
Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism.
    Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:8

    Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9;

1980
Peripheral venous concentrations of oestrogens in postmenopausal women with ovarian cancer.
    British journal of obstetrics and gynaecology, 1982, Volume: 89, Issue:1

    Topics: Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Ovarian Neopla

1982
Origin of serum estradiol in postmenopausal women.
    Obstetrics and gynecology, 1982, Volume: 59, Issue:6

    Topics: Androstenedione; Body Weight; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rat

1982
Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Cancer research, 1982, Volume: 42, Issue:8 Suppl

    Topics: Adrenal Glands; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Castration; Estradiol; Es

1982
In vivo effects of delta 1-testololactone on peripheral aromatization.
    Cancer research, 1982, Volume: 42, Issue:8 Suppl

    Topics: Aged; Androstenedione; Aromatase; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug;

1982
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
    Maturitas, 1982, Volume: 4, Issue:1

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F

1982
Plasma androstenedione and oestrone levels before and after the menopause. II. Non-endocrine ovarian tumours and cysts.
    Maturitas, 1982, Volume: 4, Issue:1

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Androstenedione; Carcinoma; Cystadenocarcinoma; Cystadenoma

1982
A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapy.
    Acta obstetricia et gynecologica Scandinavica, 1982, Volume: 61, Issue:2

    Topics: Estradiol; Estriol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Men

1982
Weight reduction and oestrogen excretion in obese post-menopausal women.
    Maturitas, 1982, Volume: 4, Issue:2

    Topics: Body Weight; Diet, Reducing; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Ob

1982
Cigarette smoking and urinary estrogens.
    The New England journal of medicine, 1982, Oct-21, Volume: 307, Issue:17

    Topics: Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M

1982
[Serum sex steroid hormones in women with aging, and in the patients of climacteric syndrome and squamous cell carcinoma of the uterus].
    Nihon Sanka Fujinka Gakkai zasshi, 1982, Volume: 34, Issue:9

    Topics: Adult; Aged; Aging; Carcinoma, Squamous Cell; Climacteric; Estradiol; Estriol; Estrone; Female; Gona

1982
Correlation of kinetics and absorption of 47Ca with estrogen and hormonal ovarian function in postmenopause.
    Metabolic bone disease & related research, 1982, Volume: 4, Issue:3

    Topics: Bone and Bones; Calcium; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Intestinal Absorpti

1982
Analysis of estrone sulphate levels in post-menopausal women with and without endometrial cancer.
    European journal of gynaecological oncology, 1982, Volume: 3, Issue:3

    Topics: Adenocarcinoma; Endometrium; Estrone; Female; Humans; Menopause; Uterine Neoplasms

1982
Estrone sulphate and estrone splanchnic extraction in postmenopausal women.
    Acta Europaea fertilitatis, 1982, Volume: 13, Issue:3

    Topics: Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Splanchnic Circulation

1982
The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight.
    Journal of steroid biochemistry, 1981, Volume: 14, Issue:11

    Topics: Aged; Aging; Castration; Circadian Rhythm; Estrone; Female; Humans; Male; Menopause; Middle Aged; Ob

1981
Total and free estrogens and androgens in postmenopausal women with hip fractures.
    The Journal of clinical endocrinology and metabolism, 1982, Volume: 54, Issue:1

    Topics: Aged; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Hip Fractures; Humans; Meno

1982
Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids.
    Acta obstetricia et gynecologica Scandinavica, 1981, Volume: 60, Issue:1

    Topics: Adult; Cholesterol; Climacteric; Estrone; Fatty Acids; Female; Humans; Lipids; Lipoproteins; Menopau

1981
Metabolic clearance rates of androgens and oestrogens in ageing women.
    Maturitas, 1980, Volume: 2, Issue:4

    Topics: Adult; Aged; Aging; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Cleara

1980
An oestrone-releasing vaginal ring in the treatment of climacteric women.
    Maturitas, 1980, Volume: 2, Issue:4

    Topics: Aged; Climacteric; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropins; Humans; M

1980
The vaginal absorption of oestrogens in post-menopausal women.
    Maturitas, 1980, Volume: 2, Issue:4

    Topics: Aged; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Time Factors; Vagina

1980
Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height.
    Maturitas, 1981, Volume: 3, Issue:1

    Topics: Androstenedione; Body Height; Body Weight; Estradiol; Estrone; Female; Humans; Menopause

1981
Obesity, hormones, and cancer.
    Cancer research, 1981, Volume: 41, Issue:9 Pt 2

    Topics: Androgens; Androstenedione; Body Weight; Estrogens; Estrone; Female; Humans; Male; Menopause; Neopla

1981
Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    British journal of obstetrics and gynaecology, 1981, Volume: 88, Issue:9

    Topics: Cell Nucleus; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans;

1981
Obese young men have elevated plasma estrogen levels but obese premenopausal women do not.
    Metabolism: clinical and experimental, 1981, Volume: 30, Issue:10

    Topics: Adult; Age Factors; Estradiol; Estrone; Female; Humans; Male; Menopause; Menstruation; Middle Aged;

1981
Changes in plasma concentrations of oestrogens and progesterone in women during anaesthesia and gynaecological operations.
    Journal of steroid biochemistry, 1981, Volume: 14, Issue:8

    Topics: Adult; Aged; Anesthesia, General; Estradiol; Estrone; Female; Genital Diseases, Female; Humans; Kine

1981
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
    The New England journal of medicine, 1981, Dec-31, Volume: 305, Issue:27

    Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydr

1981
Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes.
    Upsala journal of medical sciences, 1981, Volume: 86, Issue:3

    Topics: Absorption; Administration, Oral; Adult; Biological Availability; Estradiol; Estrone; Female; Humans

1981
Production rates of androgens and oestrogens in post-menopausal women.
    Maturitas, 1981, Volume: 3, Issue:3-4

    Topics: Age Factors; Aged; Androgens; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; H

1981
Studies of oestrogen metabolism in postmenopausal women with cancer.
    Journal of steroid biochemistry, 1981, Volume: 15

    Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estra

1981
Extraglandular estrogen production in postmenopausal women with and without endometrial cancer: comparison between "in vitro" and "in vivo" results.
    Cancer detection and prevention, 1981, Volume: 4, Issue:1-4

    Topics: Adipose Tissue; Androstenedione; Estrogens; Estrone; Female; Humans; In Vitro Techniques; Menopause;

1981
Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:1

    Topics: Adult; Aged; Androstenedione; Body Weight; Calcium; Estradiol; Estrone; Ethinyl Estradiol; Fasting;

1980
Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.
    American journal of obstetrics and gynecology, 1980, Feb-15, Volume: 136, Issue:4

    Topics: Aged; Androstenedione; Cervix Uteri; Cytosol; Estradiol; Estrone; Female; Gonadal Steroid Hormones;

1980
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
    Gynecologic oncology, 1980, Volume: 9, Issue:2

    Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge

1980
Plasma estrone sulfate levels in postmenopausal women.
    Steroids, 1980, Volume: 35, Issue:2

    Topics: Aged; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay

1980
[Various aspects of estrogenic activity during the menopause. II. Relation between excreted estrogens, Meisels cytohormonal estrogenic effects and specific types of cells in cytohormonal patterns].
    Ginekologia polska, 1980, Volume: 51, Issue:8

    Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Vagina; Vaginal Smea

1980
[Various aspects of estrogenic activity during menopause. III. Relation between estrogen excretion and the number of years after menopause].
    Ginekologia polska, 1980, Volume: 51, Issue:8

    Topics: Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Time Factors

1980
A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta.
    British journal of obstetrics and gynaecology, 1981, Volume: 88, Issue:2

    Topics: Administration, Oral; Adult; Estradiol; Estrogens; Estrone; Female; Humans; Injections, Intradermal;

1981
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
    Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:7

    Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Con

1995
Role of growth factors in the human endometrium during aging.
    Maturitas, 1993, Volume: 16, Issue:1

    Topics: Adult; Aged; Aging; Androstenedione; Endometrium; Epidermal Growth Factor; ErbB Receptors; Estradiol

1993
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Maturitas, 1995, Volume: 21, Issue:2

    Topics: Androstenedione; Body Mass Index; Bone Density; Climacteric; Estradiol; Estrone; Female; Follicle St

1995
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.
    Obstetrics and gynecology, 1995, Volume: 85, Issue:1

    Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Adult; Aged; Aged, 80

1995
The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints.
    European journal of obstetrics, gynecology, and reproductive biology, 1994, Volume: 57, Issue:2

    Topics: Adult; Aged; Aging; Arthralgia; Climacteric; Depression; Estrone; Female; Humans; Italy; Menopause;

1994
Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer?
    The Journal of steroid biochemistry and molecular biology, 1994, Volume: 51, Issue:3-4

    Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfa

1994
Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
    The Journal of steroid biochemistry and molecular biology, 1994, Volume: 48, Issue:2-3

    Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Contraceptives, Oral; Endometrial Neoplasms; Estr

1994
Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
    American journal of obstetrics and gynecology, 1993, Volume: 168, Issue:4

    Topics: Adult; Blood Pressure; Body Weight; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol C

1993
Relationship between aromatase activity and steroid receptor levels in ovarian tumors from postmenopausal women.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6

    Topics: Adult; Aged; Aged, 80 and over; Androgens; Androstenedione; Aromatase; Cystadenocarcinoma; Estradiol

1993
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4

    Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibi

1995
Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1996, Volume: 5, Issue:10

    Topics: Analysis of Variance; Blood Chemical Analysis; Estradiol; Estrogens, Conjugated (USP); Estrone; Feas

1996
Androgens and the menopause; a study of 40-60-year-old women.
    Clinical endocrinology, 1996, Volume: 45, Issue:5

    Topics: Adrenal Glands; Adult; Age Factors; Androgens; Androstenedione; Body Mass Index; Dehydroepiandroster

1996
Changes in serum estrogen levels in women during tamoxifen therapy.
    American journal of surgery, 1997, Volume: 173, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estr

1997
Characterization of the onset of menopause in the rhesus macaque.
    Biology of reproduction, 1997, Volume: 57, Issue:2

    Topics: Aging; Animals; Estrone; Female; Follicular Phase; Luteal Phase; Macaca mulatta; Menopause; Menstrua

1997
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
    Journal of hypertension, 1998, Volume: 16, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; C

1998
Evidence for interference in estradiol-17beta inactivation to estrone by oxidized low-density lipoprotein and selected lipid peroxidation products.
    The Journal of laboratory and clinical medicine, 1999, Volume: 134, Issue:3

    Topics: 17-Hydroxysteroid Dehydrogenases; Base Sequence; Breast Neoplasms; Cell Line; DNA Primers; Estradiol

1999
A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India.
    Journal of epidemiology, 1999, Volume: 9, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Antioxidants; beta Carotene; Breast Neoplas

1999
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:2

    Topics: Aged; Aged, 80 and over; Aging; Androstenedione; Estrone; Female; Gonadal Steroid Hormones; Humans;

2000
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
    International journal of cancer, 2000, Jul-15, Volume: 87, Issue:2

    Topics: Alleles; Aromatase; Breast Neoplasms; Case-Control Studies; Estradiol; Estrone; Female; Genotype; Hu

2000
Estrogen and progesterone metabolites and follicle-stimulating hormone in the aged macaque female.
    Biology of reproduction, 2001, Volume: 65, Issue:6

    Topics: Aging; Animals; Anovulation; Dehydroepiandrosterone Sulfate; Estrogens; Estrone; Female; Follicle St

2001
Association of CYP1B1 polymorphisms and breast cancer risk.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:5

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyt

2002
Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.
    Molecular and cellular endocrinology, 1977, Volume: 6, Issue:4-5

    Topics: Breast; Breast Neoplasms; Endoplasmic Reticulum; Estradiol; Estradiol Dehydrogenases; Estrone; Femal

1977
Hormone replacement therapy and endometrial carcinoma.
    Lancet (London, England), 1977, Apr-02, Volume: 1, Issue:8014

    Topics: Climacteric; Drug Evaluation; Estradiol; Estradiol Congeners; Estrone; Female; Humans; Menopause; Mi

1977
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
    Lancet (London, England), 1977, Jun-04, Volume: 1, Issue:8023

    Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dehydroepia

1977
Oestrogen in breast fluid.
    Lancet (London, England), 1977, Dec-03, Volume: 2, Issue:8049

    Topics: Adult; Body Fluids; Breast; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Menopause; M

1977
Relation between plasma oestrone and oestradiol and climacteric symptoms.
    Lancet (London, England), 1978, Apr-01, Volume: 1, Issue:8066

    Topics: Adult; Atrophy; Castration; Climacteric; Dyspareunia; Estradiol; Estrone; Female; Humans; Menopause;

1978
Smoking, obesity, and the menopause.
    Lancet (London, England), 1978, Aug-12, Volume: 2, Issue:8085

    Topics: Adult; Age Factors; Aged; Estrone; Female; Humans; Menopause; Middle Aged; Obesity; Smoking

1978
Adipose tissue and aetiology of breast cancer.
    Lancet (London, England), 1978, Sep-23, Volume: 2, Issue:8091

    Topics: Adipose Tissue; Aged; Body Weight; Breast Neoplasms; Estrone; Female; Humans; Menopause; Middle Aged

1978
Pineal gland, F.S.H., and breast-cancer aetiology.
    Lancet (London, England), 1978, Dec-16, Volume: 2, Issue:8103

    Topics: Aged; Breast Neoplasms; Estrone; Female; Follicle Stimulating Hormone; Humans; Melatonin; Menopause;

1978
Mechanism of action of aminoglutethimide in breast cancer.
    Lancet (London, England), 1979, Jan-06, Volume: 1, Issue:8106

    Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogen Antagonists;

1979
Plasma hormone levels in different ethnic populations of women.
    Cancer research, 1976, Volume: 36, Issue:7 PT 1

    Topics: Adrenal Glands; Adult; Africa; Androstenedione; Animals; Asian People; Black People; Breast Neoplasm

1976
Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Obstetrics and gynecology, 1976, Volume: 48, Issue:2

    Topics: Adrenal Cortex Hormones; Aged; Androgens; Androstenediols; Androstenedione; Dehydroepiandrosterone;

1976
Steroid hormone metabolism in skin and isolated sebaceous glands: preliminary observations on the effects of age.
    The Journal of investigative dermatology, 1979, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aging; Dehydroepiandrosterone; Estradiol; Estrone; Female; Gon

1979
Serum levels of total dehydroepiandrosterone and total estrone in postmenopausal women with special regard to carcinoma of the uterine corpus.
    Acta obstetricia et gynecologica Scandinavica, 1979, Volume: 58, Issue:2

    Topics: Aged; Dehydroepiandrosterone; Estrone; Female; Humans; Menopause; Middle Aged; Uterine Neoplasms

1979
Metabolic effects of corticosteroid therapy in post-menopausal women.
    Journal of steroid biochemistry, 1979, Volume: 11, Issue:1B

    Topics: Androstenedione; Bone and Bones; Calcium; Creatinine; Dehydroepiandrosterone; Estradiol; Estrone; Fe

1979
Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Obstetrics and gynecology, 1975, Volume: 45, Issue:3

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Androgens; Androstenedione; Dehydroepiandrosterone; Dih

1975
Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands.
    Acta endocrinologica, 1975, Volume: 78, Issue:3

    Topics: Aged; Animals; Benzoates; Binding Sites; Binding, Competitive; Blood Proteins; Centrifugation, Densi

1975
Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens.
    Journal of steroid biochemistry, 1975, Volume: 6, Issue:5

    Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Binding, Competitive; Breast Neoplasms; Dehydroep

1975
The hormonal activity of the postmenopausal ovary.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 42, Issue:2

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Androstenedione; Castration; Chorionic Gonadotrop

1976
Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women.
    Steroids, 1976, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Breast; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Nucleus; Cytosol; Estradiol

1976
Proceedings: Androgens in human postmenopausal breast cancer.
    Hormone research, 1975, Volume: 6, Issue:5-6

    Topics: Androgens; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Menopause;

1975
Management of the menopause.
    The Practitioner, 1976, Volume: 216, Issue:1295

    Topics: Atrophy; Climacteric; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol;

1976
Effect of treatment with estrogen conjugates on endogenous plasma steroids.
    Obstetrics and gynecology, 1977, Volume: 49, Issue:1

    Topics: Androstenedione; Dehydroepiandrosterone; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; F

1977
Oestrogens and endometrial cancer: a point of view.
    Clinics in obstetrics and gynaecology, 1977, Volume: 4, Issue:1

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Breast Neoplasms; Climacteric; Contraceptives, Oral, Seque

1977
Estrogens for the menopause. Maximizing benefits, minimizing risks.
    Postgraduate medicine, 1977, Volume: 62, Issue:3

    Topics: Affective Symptoms; Arteriosclerosis; Breast Neoplasms; Climacteric; Cystitis; Estradiol; Estrogens;

1977
Adrenal contribution to circulating estrogens in woman.
    Endocrinologia japonica, 1978, Volume: 25, Issue:2

    Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Estradiol

1978
Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
    British journal of obstetrics and gynaecology, 1978, Volume: 85, Issue:12

    Topics: Administration, Oral; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating

1978
[Estrogen substitution and endometrial carcinoma].
    Nederlands tijdschrift voor geneeskunde, 1979, Mar-10, Volume: 123, Issue:10

    Topics: Aged; Endometriosis; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Men

1979
Plasma hormone levels and oestrogen production in a postmenopausal woman with endometrial carcinoma and an ovarian thecoma.
    Clinical endocrinology, 1979, Volume: 11, Issue:2

    Topics: Adenocarcinoma; Androstenedione; Castration; Estradiol; Estrone; Female; Hormones; Humans; Hysterect

1979
Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
    Maturitas, 1979, Volume: 1, Issue:3

    Topics: Castration; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (

1979
Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis.
    Steroids, 1979, Volume: 34, Issue:5

    Topics: Adult; Aged; Dehydroepiandrosterone; Estrogens, Conjugated (USP); Estrone; Female; Humans; Liver Cir

1979
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:6

    Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female;

1978
Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1977, Volume: 65

    Topics: Administration, Oral; Adult; Aged; Estradiol; Estrone; Female; Humans; Intestinal Absorption; Menopa

1977
Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
    Journal of the National Cancer Institute, 1979, Volume: 63, Issue:5

    Topics: Aged; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Risk

1979
Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
    Australian and New Zealand journal of medicine, 1979, Volume: 9, Issue:1

    Topics: Aged; Androstenedione; Calcium; Ergocalciferols; Estradiol; Estrone; Ethinyl Estradiol; Female; Huma

1979
Endocrine diagnosis in the climacteric female.
    Hormone research, 1978, Volume: 9, Issue:6

    Topics: Adult; Androstenedione; Chorionic Gonadotropin; Climacteric; Estradiol; Estrone; Female; Follicle St

1978
Inhibition of peripheral aromatization in postmenopausal women with breast cancer.
    Surgical forum, 1978, Volume: 29

    Topics: Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Menopause; Radioimmunoassay; Testolacton

1978
Deuterium-labeled steroids for study in humans. II. Preliminary studies on estrogen production rates in pre- and post-menopausal women.
    Hormone research, 1979, Volume: 10, Issue:1

    Topics: Adult; Age Factors; Chromatography, Gas; Deuterium; Estradiol; Estriol; Estrogens; Estrone; Female;

1979
Low urinary estrogen glucuronides in women at risk for familial breast cancer.
    Science (New York, N.Y.), 1979, Jun-08, Volume: 204, Issue:4397

    Topics: Adult; Age Factors; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopa

1979
[Metabolism of estrone sulfate in the postmenopausal and the pregnant myometrium].
    Archives of gynecology, 1979, Jul-20, Volume: 228, Issue:1-4

    Topics: Estrone; Female; Humans; Menopause; Myometrium; Pregnancy; Uterus

1979
Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:5

    Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Mastectomy; Menopause;

1979
Factors affecting sex hormone levels in postmenopausal women.
    Journal of steroid biochemistry, 1979, Volume: 11, Issue:1C

    Topics: Addison Disease; Adipose Tissue; Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; E

1979
The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer.
    Journal of steroid biochemistry, 1979, Volume: 11, Issue:1C

    Topics: Adenocarcinoma; Adult; Androstenedione; Castration; Estrone; Female; Humans; Hysterectomy; Menopause

1979
Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women.
    Acta endocrinologica, 1979, Volume: 92, Issue:2

    Topics: Aged; Castration; Cholesterol; Drug Therapy, Combination; Estradiol; Estrogens; Estrone; Ethinyl Est

1979
Androgen--oestrogen transformation in female patients with metastatic breast cancer.
    Clinical oncology, 1979, Volume: 5, Issue:3

    Topics: Bone Neoplasms; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Testosterone

1979
Uterine metabolism of gonadal steroids during the menstrual cycle.
    American journal of obstetrics and gynecology, 1979, Dec-01, Volume: 135, Issue:7

    Topics: Adult; Carbon Radioisotopes; Estradiol; Estrone; Female; Genital Diseases, Female; Humans; Menopause

1979
Hormone replacement therapy in the menopause: a suitable animal model.
    The Journal of endocrinology, 1979, Volume: 83, Issue:1

    Topics: Animals; Cytosol; Endometrium; Estrone; Ethinyl Estradiol; Female; Femur; Genitalia, Female; Luteini

1979
Relation between the karyopyknotic index and plasma oestrogen concentrations after the menopause.
    British journal of obstetrics and gynaecology, 1979, Volume: 86, Issue:12

    Topics: Aged; Cell Nucleus; Dyspareunia; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Ag

1979
Androgen-estrogen production rates in postmenopausal women with breast cancer.
    Cancer research, 1978, Volume: 38, Issue:11 Pt 2

    Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Cl

1978
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls.
    Upsala journal of medical sciences, 1979, Volume: 84, Issue:3

    Topics: Age Factors; Aged; Androstenedione; Body Weight; Breast Neoplasms; Estrone; Female; Humans; Menopaus

1979
Estrogen use and cancer risk.
    JAMA, 1977, Mar-14, Volume: 237, Issue:11

    Topics: Administration, Oral; Breast Neoplasms; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrad

1977
Effect of piperazine oestrone sulphate on serum lipids and lipoproteins in menopausal women.
    Acta endocrinologica, 1977, Volume: 85, Issue:1

    Topics: Cholesterol; Climacteric; Estrone; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Lipids;

1977
Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.
    British medical journal, 1977, Nov-05, Volume: 2, Issue:6096

    Topics: Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopause; Middle Aged; Osteoporo

1977
The influence of nandrolone decanoate (Deca-durabolin) on the peripheral conversion of androstenedione to oestrone.
    Journal of steroid biochemistry, 1977, Volume: 8, Issue:12

    Topics: Androstenedione; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged; Nandrolo

1977
Effect of diabetic status on fractionated estrogen levels in postmenopausal women.
    American journal of obstetrics and gynecology, 1978, Jan-01, Volume: 130, Issue:1

    Topics: Adenocarcinoma; Diabetes Complications; Diabetes Mellitus; Estradiol; Estrone; Female; Humans; Menop

1978
The relation between plasma androstenedione, plasma oestrone and androstenedione to oestrone conversion rates in post-menopausal women with and without fractures.
    Clinical science and molecular medicine, 1978, Volume: 54, Issue:2

    Topics: Adrenal Glands; Age Factors; Aged; Androstenedione; Castration; Estrone; Female; Fractures, Bone; Hu

1978
Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.
    American journal of obstetrics and gynecology, 1978, Feb-15, Volume: 130, Issue:4

    Topics: Adenocarcinoma; Aged; Aging; Androstenedione; Estrogens; Estrone; Female; Humans; Menopause; Middle

1978
Estriol in the management of the menopause.
    JAMA, 1978, Apr-21, Volume: 239, Issue:16

    Topics: Endometrium; Estriol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Me

1978
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    British journal of obstetrics and gynaecology, 1978, Volume: 85, Issue:5

    Topics: Estradiol; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hor

1978
Peripheral production of oestrogens in postmenopausal women [proceedings].
    The Journal of endocrinology, 1978, Volume: 77, Issue:2

    Topics: Androgens; Androstenedione; Dexamethasone; Estrone; Female; Humans; Menopause; Middle Aged; Testoste

1978
Estrogen synthesis and estradiol binding by human mammary tumors.
    Cancer research, 1978, Volume: 38, Issue:8

    Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Age Factors; Aged; Androstenedione; Breast Neoplasms; Estra

1978
Sex hormone concentrations in post-menopausal women.
    Clinical endocrinology, 1978, Volume: 9, Issue:1

    Topics: Age Factors; Aged; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Obes

1978
[Clinical evaluation of estro-feminal preparation].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1978, May-01, Volume: 31, Issue:9

    Topics: Administration, Oral; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged

1978
Preoperative localization of virilizing tumors by selective venous sampling.
    American journal of obstetrics and gynecology, 1978, Aug-01, Volume: 131, Issue:7

    Topics: Adrenal Glands; Adrenal Rest Tumor; Androgens; Androstenedione; Chorionic Gonadotropin; Estrone; Fem

1978
Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
    Cancer research, 1978, Volume: 38, Issue:10

    Topics: Adenocarcinoma; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Menstrua

1978
Relationship between urine and plasma estrogen ratios.
    Cancer research, 1978, Volume: 38, Issue:11 Pt 2

    Topics: Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Follicular Phase; Humans; Luteal P

1978
Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women.
    Journal of the Royal Society of Medicine, 1978, Volume: 71, Issue:10

    Topics: Adrenal Cortex Hormones; Androstenedione; Creatinine; Estrone; Female; Humans; Hydroxyproline; Menop

1978
Kinetics of testosterone metabolism in normal postmenopausal women and women with breast cancer.
    Steroids, 1978, Volume: 32, Issue:3

    Topics: Aged; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Kinetics; Menopause; Metabolic Clearance

1978
The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.
    Clinical endocrinology, 1978, Volume: 9, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopaus

1978
Plasma hormone profiles after the menopause and bilateral oöphorectomy.
    Postgraduate medical journal, 1978, Volume: 54 Suppl 2

    Topics: Aged; Androstenedione; Castration; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans;

1978
Estriol production rates and breast cancer.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 46, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged

1978
The effects of oestrogens and progestogens on the postmenopausal endometrium.
    Maturitas, 1978, Volume: 1, Issue:2

    Topics: Endometrial Hyperplasia; Endometrium; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M

1978
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
    British journal of obstetrics and gynaecology, 1979, Volume: 86, Issue:1

    Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal

1979
The hypothalamic anterior pituitary system in the clinacteric age period.
    Frontiers of hormone research, 1975, Volume: 3

    Topics: Castration; Climacteric; Estrone; Female; Follicle Stimulating Hormone; Follicular Phase; Gonadotrop

1975
Influence of thyrotropin-releasing hormone on the postmenopausal female.
    Obstetrics and gynecology, 1975, Volume: 45, Issue:1

    Topics: Administration, Oral; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing

1975
The management of the menopause.
    Scottish medical journal, 1977, Volume: 22, Issue:1

    Topics: Adult; Climacteric; Estrogens; Estrone; Female; Humans; Menopause; Neoplasms; Pregnancy; Progesteron

1977
Changes in reproductive hormone secretion during the climacteric and postmenopausal periods.
    Clinical obstetrics and gynecology, 1977, Volume: 20, Issue:1

    Topics: Aging; Androgens; Climacteric; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadal Ste

1977
Plasma hormones in human gonadotropin induced ovulation.
    Obstetrics and gynecology, 1977, Volume: 49, Issue:3

    Topics: Adult; Androstenedione; Anovulation; Chorionic Gonadotropin; Estradiol; Estrone; Female; Follicle St

1977
Postmenopausal bleeding.
    Clinics in obstetrics and gynaecology, 1977, Volume: 4, Issue:1

    Topics: Adenocarcinoma; Adrenal Glands; Androstenedione; Contraceptives, Oral; Dilatation and Curettage; End

1977
Steroidogenesis in the postmenopausal ovary.
    Clinics in obstetrics and gynaecology, 1977, Volume: 4, Issue:1

    Topics: Adenocarcinoma; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Gonadal Steroid H

1977
Basic levels of the immuno suppressive serum protein PZ in women-influence of age, parity, gonadotrophins and estrogens.
    Acta obstetricia et gynecologica Scandinavica, 1977, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Ho

1977
The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas.
    Obstetrics and gynecology, 1977, Volume: 49, Issue:6

    Topics: Aged; Androgens; Androstenedione; Dermoid Cyst; Estradiol; Estrogens; Estrone; Female; Humans; Menop

1977
Relationship between steroid excretion patterns and breast cancer incidence in Israeli women of various origins.
    Journal of the National Cancer Institute, 1977, Volume: 59, Issue:1

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androgens; Breast Neoplasms; Environment; Estriol; E

1977
Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 45, Issue:3

    Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Castration; Estradiol; Estroge

1977
Vaginal absorption of estrone and 17beta-estradiol.
    Fertility and sterility, 1977, Volume: 28, Issue:10

    Topics: Aged; Biopharmaceutics; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizin

1977
Clinical and endocrine studies in menopausal women after estradiol pellet implantation.
    Obstetrics and gynecology, 1977, Volume: 50, Issue:5

    Topics: Adult; Depression, Chemical; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lutei

1977
Androstenedione metabolism in patients with endometrial cancer.
    American journal of obstetrics and gynecology, 1977, Nov-01, Volume: 129, Issue:5

    Topics: Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Testostero

1977
Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Annals of internal medicine, 1977, Volume: 87, Issue:6

    Topics: Adult; Aged; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Neoplasm

1977
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
    Obstetrics and gynecology, 1976, Volume: 47, Issue:6

    Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe

1976
Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:2

    Topics: Adenocarcinoma; Aged; Androgens; Body Weight; Castration; Estradiol; Estrone; Female; Humans; Menopa

1976
Intestinal metabolism of estrogens.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:3

    Topics: Ampicillin; Estrogens; Estrone; Feces; Female; Humans; Intestinal Mucosa; Menopause; Pregnancy

1976
Breast cancer in Britain and Japan: plasma oestradiol-17beta, oestrone and progesterone,and their urinary metabolites in normal British and Japanese women.
    European journal of cancer, 1976, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Factors; Asian People; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estro

1976
Hormonal profiles after the menopause.
    British medical journal, 1976, Oct-02, Volume: 2, Issue:6039

    Topics: Age Factors; Aged; Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormon

1976
[Experimentation on the combination of estrone monosodium sulfate and estradiol monosodium sulfate in the treatment of menopause].
    Revue francaise de gynecologie et d'obstetrique, 1976, Volume: 71, Issue:12

    Topics: Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Menopause

1976
Correlation between urinary testosterone or estrogen excretion levels and interstitial cell-stimulating hormone concentrations in normal postmenopausal women.
    American journal of obstetrics and gynecology, 1975, Feb-01, Volume: 121, Issue:3

    Topics: Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Luteinizing Hormone; Menopause; Testoste

1975
Duration of effect of treatment of menopausal symptoms by oestrongen fraction.
    Current medical research and opinion, 1975, Volume: 3, Issue:1

    Topics: Estradiol; Estrone; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Piperazines

1975
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:3

    Topics: Administration, Oral; Adult; Aged; Depression, Chemical; Estradiol; Estrone; Female; Follicle Stimul

1975
The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women.
    American journal of obstetrics and gynecology, 1975, Mar-15, Volume: 121, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Alkynes; Endometriosis; Estradiol; Estrogen Antag

1975
Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Androstenedione; Body Height; Body Weight; Endometrium; Estriol; Estrog

1975
Protection of estrogenic hormones by ascorbic acid during chromatography.
    Steroids, 1975, Volume: 25, Issue:3

    Topics: Aged; Ascorbic Acid; Breast Neoplasms; Chromatography, Gas; Chromatography, Thin Layer; Estradiol; E

1975
[Estradiol-17beta, estrone, LH and FSH in serum after administration of estradiol-17beta, estradiolbenzoate, estradiol-valeriate and estradiol-undecylate in the female (author's transl)].
    Geburtshilfe und Frauenheilkunde, 1975, Volume: 35, Issue:5

    Topics: Adult; Benzoates; Castration; Dose-Response Relationship, Drug; Esters; Estradiol; Estrone; Female;

1975
Urinary excretion of steroids and response to oophorectomy in premenopausal women with advanced breast cancer.
    Gan, 1975, Volume: 66, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adult; Breast Neoplasms; Castra

1975
Post-menopausal estrogen production.
    Frontiers of hormone research, 1975, Volume: 3

    Topics: Androstenedione; Estrogens; Estrone; Female; Humans; Menopause; Pregnancy; Steroid Hydroxylases; Ute

1975
Association of estrone with the development of endometrial carcinoma.
    American journal of obstetrics and gynecology, 1976, Apr-01, Volume: 124, Issue:7

    Topics: Androstenedione; Animals; Estradiol; Estrone; Female; Humans; Menopause; Time Factors; Uterine Neopl

1976
Increasing incidence of endometrial cancer in the United States.
    The New England journal of medicine, 1976, Jun-03, Volume: 294, Issue:23

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Androstenedione; Contraceptives, Oral; Estrogens; Estrone;

1976
[Effect of oestro-feminal on lipid metabolism in postmenopausal women].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1992, Volume: 45, Issue:17-18

    Topics: Adult; Arteriosclerosis; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Menopause; Mi

1992
On the significance of in situ production of oestrogens in human breast cancer tissue.
    The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8

    Topics: Adipose Tissue; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estr

1992
25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
    British journal of obstetrics and gynaecology, 1992, Volume: 99, Issue:8

    Topics: Drug Implants; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female

1992
The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1992, Volume: 24, Issue:11

    Topics: Aged; Breast; Breast Neoplasms; Danazol; Estrone; Female; Humans; Menopause; Middle Aged; Sulfatases

1992
Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
    European journal of obstetrics, gynecology, and reproductive biology, 1992, Nov-19, Volume: 47, Issue:2

    Topics: Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Th

1992
Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy.
    Gynecologic and obstetric investigation, 1992, Volume: 34, Issue:4

    Topics: Atrophy; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Urethra; Vagi

1992
Endocrine evaluation of patients with benign lumps of the breast.
    Cancer detection and prevention, 1992, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; E

1992
Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1992, Volume: 6, Issue:1

    Topics: Abdomen; Adipose Tissue; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause

1992
Influence of estrogen replacement therapy on endogenous calcitonin production rates.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1992, Volume: 6, Issue:1

    Topics: Aged; Aged, 80 and over; Calcitonin; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Human

1992
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase I

1991
High-fiber diet reduces serum estrogen concentrations in premenopausal women.
    The American journal of clinical nutrition, 1991, Volume: 54, Issue:3

    Topics: Adult; Dietary Fats; Dietary Fiber; Edible Grain; Estrogens; Estrone; Female; Humans; Menopause; Mid

1991
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7

    Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas

1991
Alpha 2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women.
    Calcified tissue international, 1990, Volume: 47, Issue:6

    Topics: Aged; Alleles; alpha-Macroglobulins; Bone Density; Cohort Studies; Estradiol; Estrogens; Estrone; Fe

1990
Endogenous factors affecting bone mineral content in post-menopausal women.
    Maturitas, 1991, Volume: 13, Issue:4

    Topics: Adult; Aged; Aging; Body Composition; Bone Density; Creatinine; Estrone; Female; Humans; Menopause;

1991
Sex hormones in postmenopausal women with primary biliary cirrhosis.
    Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:5

    Topics: Aged; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Gona

1991
Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease.
    Journal of hepatology, 1991, Volume: 13, Issue:1

    Topics: Aged; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone;

1991
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1991, Volume: 5, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroep

1991
Tamoxifen and partial oestrogen agonism in postmenopausal women.
    Age and ageing, 1991, Volume: 20, Issue:1

    Topics: Aged; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans;

1991
Reliability and interrelations among serum sex hormones in postmenopausal women.
    American journal of epidemiology, 1991, Volume: 133, Issue:1

    Topics: Androstenedione; Cholesterol, HDL; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Regre

1991
Endometrial cancer, obesity, and body fat distribution.
    Cancer research, 1991, Jan-15, Volume: 51, Issue:2

    Topics: Adipose Tissue; Adult; Aged; Androstenedione; Body Mass Index; Case-Control Studies; Estradiol; Estr

1991
Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:2

    Topics: Cholesterol; Cholesterol Esters; Estrone; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; L

1991
[Influences of menopause and oophorectomy on bone metabolism and spinal bone mineral content].
    Nihon Sanka Fujinka Gakkai zasshi, 1991, Volume: 43, Issue:4

    Topics: Alkaline Phosphatase; Androstenedione; Bone and Bones; Bone Density; Calcium; Estrone; Female; Human

1991
[Plasma estrogen level in patients with cervical cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1990, Volume: 12, Issue:6

    Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Estradiol; Estriol; Estrogens; Estrone; Female; Huma

1990
The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:1

    Topics: Amenorrhea; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Body Mass Index; Cholesterol;

1990
Smoking induces increased androgen levels in early post-menopausal women.
    Maturitas, 1990, Volume: 12, Issue:2

    Topics: Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormo

1990
Influence of menopause on serum lipids and lipoproteins.
    Maturitas, 1990, Volume: 12, Issue:4

    Topics: Adult; Aged; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins;

1990
Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan.
    British journal of cancer, 1990, Volume: 62, Issue:3

    Topics: Aged; Asian People; Estradiol; Estrogens; Estrone; Female; Humans; Japan; Menopause; Middle Aged; Se

1990
Androgen and estrogen dynamics: stability over a two year interval in peri-menopausal women.
    Journal of steroid biochemistry, 1990, Volume: 35, Issue:1

    Topics: Androgens; Androstenedione; Aromatase; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Met

1990
Differential effects of oral estrone versus 17 beta-estradiol on lipoproteins in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:6

    Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, D

1990
[Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology].
    Bulletin du cancer, 1990, Volume: 77, Issue:4

    Topics: Adult; Age Factors; Aged; Binding Sites; Breast Neoplasms; Carcinoma; Estrone; Female; Fluorescence;

1990
Steroids in normal and neoplastic breast tissues.
    Annals of the New York Academy of Sciences, 1990, Volume: 595

    Topics: Androgens; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Steroids

1990
Gonadotrophin response to releasing hormone in post-menopausal patients with ovarian tumours.
    Maturitas, 1989, Volume: 11, Issue:2

    Topics: Aged; Androstenedione; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; M

1989
Ovarian-pituitary hormone interactions during the perimenopause.
    Maturitas, 1989, Volume: 11, Issue:4

    Topics: Adult; Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Longitudinal

1989
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
    British journal of cancer, 1989, Volume: 59, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin;

1989
Zoladex: therapeutic effects in postmenopausal breast cancer.
    Hormone research, 1989, Volume: 32 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin;

1989
Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids.
    Clinical endocrinology, 1989, Volume: 31, Issue:3

    Topics: Estrone; Female; Humans; Leiomyoma; Luteal Phase; Menopause; Pregnanediol; Progesterone; Sex Hormone

1989
Urinary oestrogen excretion after the menopause in relation to age and body mass.
    Annals of nutrition & metabolism, 1989, Volume: 33, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Body Height; Body Mass Index; Body Weight; Creatinine; Estradi

1989
Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.
    Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6

    Topics: Androstenedione; Breast Neoplasms; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause;

1989
Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Androgens; Breast; Breast Neoplasms; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Men

1989
[Estrogen production in epithelial tumors of the ovary--localization of estrogen-synthesizing cells].
    Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:11

    Topics: Autoradiography; Cholesterol; Cystadenocarcinoma; Estradiol; Estrogens; Estrone; Female; Histocytoch

1989
The epidemiology of serum sex hormones in postmenopausal women.
    American journal of epidemiology, 1989, Volume: 129, Issue:6

    Topics: Aged; Alcohol Drinking; Androstenedione; Estradiol; Estrone; Exercise; Female; Gonadal Steroid Hormo

1989
Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women.
    Gynecologic and obstetric investigation, 1989, Volume: 27, Issue:4

    Topics: Absorption; Aged; Drug Combinations; Epithelial Cells; Epithelium; Estradiol; Estrone; Female; Human

1989
Multiple forms of 17 beta-hydroxysteroid oxidoreductase in human breast tissue.
    Journal of molecular endocrinology, 1989, Volume: 2, Issue:1

    Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Breast; Cell Fractionation; Chromatography, Gel; E

1989
[Ovarian production of estrogen in postmenopausal women with endometrial carcinoma].
    Ceskoslovenska gynekologie, 1989, Volume: 54, Issue:5

    Topics: Adenocarcinoma; Aged; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Ovary;

1989
[Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue].
    Nihon Geka Gakkai zasshi, 1989, Volume: 90, Issue:6

    Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Aromatase; Breast; Breast Neoplasms; Estrone; Female

1989
Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.
    The Journal of clinical investigation, 1989, Volume: 83, Issue:3

    Topics: Adult; Aged; Calcitonin; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged;

1989
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
    British journal of cancer, 1985, Volume: 52, Issue:4

    Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroep

1985
Uptake and concentration of steroid hormones in mammary tissues.
    Annals of the New York Academy of Sciences, 1986, Volume: 464

    Topics: Adult; Androgens; Androstenediol; Biopsy; Breast; Breast Diseases; Breast Neoplasms; Cell Nucleus; C

1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug E

1986
Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
    Breast cancer research and treatment, 1986, Volume: 7 Suppl

    Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms

1986
Serum steroid hormone profiles in postmenopausal smokers and nonsmokers.
    Fertility and sterility, 1987, Volume: 47, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfat

1987
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
    British journal of cancer, 1987, Volume: 55, Issue:3

    Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandroste

1987
Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.
    British medical journal (Clinical research ed.), 1987, Mar-28, Volume: 294, Issue:6575

    Topics: Addison Disease; Adult; Aged; Androgens; Androstenedione; Bone and Bones; Dehydroepiandrosterone; Es

1987
A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens.
    Maturitas, 1986, Volume: 8, Issue:4

    Topics: Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female;

1986
Cigarette smoking and levels of adrenal androgens in postmenopausal women.
    The New England journal of medicine, 1988, Jun-30, Volume: 318, Issue:26

    Topics: Adrenal Glands; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sul

1988
[Changes in plasma binding protein of sex steroids and transcortin during the treatment of menopause with oral estrogens].
    Presse medicale (Paris, France : 1983), 1988, Jun-11, Volume: 17, Issue:23

    Topics: Administration, Oral; Estradiol; Estrogens; Estrone; Female; Gonadotropins; Humans; Menopause; Middl

1988
Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer.
    Cancer, 1988, Dec-15, Volume: 62, Issue:12

    Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Follicle Stimulating

1988
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
    British journal of cancer, 1988, Volume: 58, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepi

1988
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
    Acta obstetricia et gynecologica Scandinavica, 1985, Volume: 64, Issue:1

    Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combi

1985
Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
    Acta obstetricia et gynecologica Scandinavica, 1985, Volume: 64, Issue:2

    Topics: Aged; Endometrium; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hor

1985
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.
    Clinical endocrinology, 1985, Volume: 22, Issue:2

    Topics: Adrenocorticotropic Hormone; Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast

1985
Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women.
    Hormone research, 1985, Volume: 21, Issue:3

    Topics: Administration, Oral; Adult; Biotransformation; Castration; Estradiol; Estriol; Estrogens, Conjugate

1985
Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    American journal of obstetrics and gynecology, 1985, Aug-15, Volume: 152, Issue:8

    Topics: Administration, Oral; Administration, Topical; Climacteric; Dosage Forms; Estradiol; Estrogens; Estr

1985
Sex steroids modulate prolactin response to naloxone in postmenopausal women.
    Neuroendocrinology, 1985, Volume: 41, Issue:2

    Topics: Endorphins; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; H

1985
Biologic effects of transdermal estradiol.
    The New England journal of medicine, 1986, Jun-19, Volume: 314, Issue:25

    Topics: Administration, Oral; Administration, Topical; Blood Coagulation Factors; Calcium; Carrier Proteins;

1986
Prevention of endometrial abnormalities.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1986, Volume: 134

    Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female

1986
Solid-phase enzymoimmunoassay of estrone in serum.
    Clinical chemistry, 1988, Volume: 34, Issue:9

    Topics: Antibody Specificity; Chromatography, Ion Exchange; Clomiphene; Estrone; Female; Humans; Immune Sera

1988
Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:3

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Angiotensinogen; Antithrombins; Estradio

1986
Oestrogen production and metabolism in peri-menopausal women.
    Maturitas, 1986, Volume: 8, Issue:1

    Topics: Breast Neoplasms; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Horm

1986
The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
    Clinical endocrinology, 1986, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans

1986
The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.
    Calcified tissue international, 1986, Volume: 38, Issue:6

    Topics: Aged; Androstenedione; Bone and Bones; Bone Resorption; Estradiol; Estrogens; Estrone; Female; Human

1986
Gonadal steroids, gonadotropins and endometrial histology in postmenopausal women with malignant ovarian tumors.
    Acta obstetricia et gynecologica Scandinavica, 1986, Volume: 65, Issue:3

    Topics: Adult; Endometrium; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormon

1986
Steroid and gonadotropin levels in women during the peri-menopausal years.
    Maturitas, 1986, Volume: 8, Issue:3

    Topics: Androgens; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing

1986
Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:3

    Topics: Amenorrhea; Animals; Contraceptives, Oral; Estrone; Female; Follicle Stimulating Hormone; Gorilla go

1987
Endometrium and plasma hormone profile in the peri-menopause and post-menopause.
    Maturitas, 1986, Volume: 8, Issue:4

    Topics: Atrophy; Endometrium; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing

1986
[Sex hormones and the hypophyseo-gonadal axis in females with liver cirrhosis in postmenopause].
    Klinische Wochenschrift, 1987, May-04, Volume: 65, Issue:9

    Topics: Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones;

1987
Vaginal physiology in postmenopausal women: pH value, transvaginal electropotential difference, and estimated blood flow.
    Southern medical journal, 1987, Volume: 80, Issue:8

    Topics: Blood Flow Velocity; Electrophysiology; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hu

1987
Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women.
    European journal of obstetrics, gynecology, and reproductive biology, 1988, Volume: 27, Issue:2

    Topics: Adult; Drug Combinations; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonad

1988
Progestins increase endogenous opioid peptide activity in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:1

    Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medr

1985
Serum levels of dehydroepiandrosterone sulphate and total estrone in postmenopausal women with special regard to 'non-endocrine' ovarian carcinoma.
    Acta obstetricia et gynecologica Scandinavica, 1985, Volume: 64, Issue:3

    Topics: Age Factors; Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans;

1985
Conversion of estrone to estradiol and estradiol to estrone in postmenopausal women.
    Obstetrics and gynecology, 1985, Volume: 66, Issue:3

    Topics: Aged; Body Weight; Breast Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradio

1985
Evaluation of urinary oestrogen assays after the menopause and their potential for screening.
    Clinica chimica acta; international journal of clinical chemistry, 1988, Aug-15, Volume: 176, Issue:1

    Topics: Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Microchemistry; Middle Aged; Radioimmunoas

1988
[Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women].
    Revista espanola de fisiologia, 1988, Volume: 44, Issue:1

    Topics: Aging; Androstenedione; Estrone; Female; Humans; Menopause; Obesity

1988
Metabolism of estrone sulfate in postmenopausal vaginal mucosa.
    Acta obstetricia et gynecologica Scandinavica, 1988, Volume: 67, Issue:3

    Topics: Estrone; Female; Humans; Menopause; Middle Aged; Mucous Membrane; Vagina

1988
[Serum estrone sulfate levels in patients with breast cancer].
    Nihon Geka Gakkai zasshi, 1988, Volume: 89, Issue:8

    Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Estrone; Female; Humans; Kinetics; Menopau

1988
Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
    Breast cancer research and treatment, 1988, Volume: 12, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Immunohistoche

1988
[Changes in plasma sex hormone in postmenopausal type II diabetics and therapeutic effect of diagnosis and treatment with traditional Chinese medicine].
    Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1988, Volume: 8, Issue:5

    Topics: Aged; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Estradiol; Estrone; Female; Gonadal Steroid

1988
Biological and endocrine aspects of transdermal 17 beta-oestradiol administration in post-menopausal women.
    Maturitas, 1988, Volume: 10, Issue:4

    Topics: Administration, Cutaneous; Blood Proteins; Estradiol; Estrone; Female; Humans; Menopause; Middle Age

1988
Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures.
    JAMA, 1988, Dec-02, Volume: 260, Issue:21

    Topics: Age Factors; Androstenedione; Animals; Bone and Bones; Calcium, Dietary; Estrogens; Estrone; Exercis

1988
Response to human chorionic gonadotropin in patients with ovarian tumors.
    Acta obstetricia et gynecologica Scandinavica, 1988, Volume: 67, Issue:7

    Topics: Aged; Androstenedione; Chorionic Gonadotropin; Estradiol; Estrone; Female; Humans; Menopause; Middle

1988
[Concentration of steroid hormones in the ovarian vein and peripheral blood and the influence of ovariectomy on postmenopausal women].
    Zhonghua fu chan ke za zhi, 1988, Volume: 23, Issue:6

    Topics: Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Ovariectomy; Ovary; Postoperative Period

1988
[Plasma concentration of estrogens and androgens in postmenopausal women with or without endometrial cancer].
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:6

    Topics: Aged; Androgens; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; Humans; Insuli

1988
Re: "Sex hormone levels in serum in relation to the development of breast cancer".
    American journal of epidemiology, 1988, Volume: 127, Issue:1

    Topics: Breast Neoplasms; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause

1988
Postmenopausal urinary incontinence: comparison between non-estrogen-supplemented and estrogen-supplemented women.
    Obstetrics and gynecology, 1988, Volume: 71, Issue:6 Pt 1

    Topics: Administration, Oral; Age Factors; Aged; Analysis of Variance; Estradiol; Estrogens; Estrone; Female

1988
Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:2

    Topics: Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; O

1988
Serum lipids in Finnish and Japanese postmenopausal women.
    Atherosclerosis, 1987, Volume: 68, Issue:3

    Topics: Apolipoproteins; Cholesterol; Estrone; Fatty Acids; Female; Finland; Humans; Japan; Lipids; Menopaus

1987
Comparative metabolism of oestrone sulphate after oral and intravenous administration in post-menopausal women.
    Maturitas, 1987, Volume: 9, Issue:3

    Topics: Administration, Oral; Estradiol; Estrone; Female; Humans; Injections, Intravenous; Liver; Menopause;

1987
Estrogens and breast cancer.
    Annals of the New York Academy of Sciences, 1986, Volume: 464

    Topics: Adult; Aged; Blood Specimen Collection; Breast Neoplasms; Epidemiologic Methods; Estradiol; Estrogen

1986
Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.
    Journal of the National Cancer Institute, 1987, Volume: 79, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Body Fluids; Breast; Breast Diseases; Breast Neoplasms; Estradiol

1987
Sex steroids and bone mass. A study of changes about the time of menopause.
    The Journal of clinical investigation, 1987, Volume: 80, Issue:5

    Topics: Adult; Bone and Bones; Calcium-Binding Proteins; Diet; Estradiol; Estrone; Female; Gonadal Steroid H

1987
Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance.
    Oncology, 1987, Volume: 44, Issue:1

    Topics: Androstenedione; Aromatase; Breast Neoplasms; Estrone; Female; Humans; In Vitro Techniques; Menopaus

1987
Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areas.
    Acta obstetricia et gynecologica Scandinavica, 1987, Volume: 66, Issue:2

    Topics: Abdomen; Administration, Cutaneous; Aged; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged

1987
Demystifying menopause.
    The Canadian nurse, 1987, Volume: 83, Issue:7

    Topics: Adult; Climacteric; Diet; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Physical Exert

1987
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:5

    Topics: Adult; Aged; Bone and Bones; Densitometry; Estradiol; Estrone; Female; Humans; Lumbar Vertebrae; Men

1986
Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women.
    Journal of steroid biochemistry, 1986, Volume: 24, Issue:1

    Topics: Aged; Androgens; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Age

1986
Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology.
    Maturitas, 1986, Volume: 8, Issue:1

    Topics: Adenocarcinoma; Aged; Androstenedione; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans;

1986
Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue.
    Journal of steroid biochemistry, 1986, Volume: 24, Issue:5

    Topics: Abdomen; Adipose Tissue; Androstenedione; Aromatase; Breast; Estradiol; Estrone; Female; Humans; Hyd

1986
The endogenous concentration of estradiol and estrone in pathological human postmenopausal endometrium.
    Journal of steroid biochemistry, 1986, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Aged; Endometrium; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Uteri

1986
Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women.
    Obstetrics and gynecology, 1986, Volume: 68, Issue:1

    Topics: Aged; Androstenedione; Cystadenocarcinoma; Cystadenoma; Estradiol; Estrone; Female; Humans; Menopaus

1986
A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women.
    International journal of cancer, 1986, Aug-15, Volume: 38, Issue:2

    Topics: Aged; Breast; Breast Neoplasms; Estradiol; Estradiol Dehydrogenases; Estrone; Female; Humans; Menopa

1986
Aromatization by skeletal muscle.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:3

    Topics: Aged; Androstenedione; Aromatase; Carbon Radioisotopes; Estrone; Female; Humans; In Vitro Techniques

1986
Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations.
    American journal of obstetrics and gynecology, 1986, Volume: 155, Issue:2

    Topics: Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Middle Aged; Pituitary Horm

1986
Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects.
    Breast cancer research and treatment, 1986, Volume: 7 Suppl

    Topics: Aminoglutethimide; Breast Neoplasms; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Fe

1986
Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
    Cancer detection and prevention, 1986, Volume: 9, Issue:3-4

    Topics: Danazol; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged; Pregnadienes

1986
Dermal prostacyclin, thromboxane A2 and prostaglandin F2 alpha in climacteric women: effect of oestrogen replacement therapy.
    Maturitas, 1986, Volume: 8, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Dinoprost; Drug Therapy, Combination; Estradiol; Estrone; Female; Huma

1986
The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women.
    American journal of epidemiology, 1986, Volume: 124, Issue:5

    Topics: Aged; Anthropometry; Bone and Bones; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Phy

1986
Diagnostic significance of steroid hormones in patients with ovarian cancer.
    Journal of endocrinological investigation, 1986, Volume: 9, Issue:4

    Topics: Adult; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Ovarian Cysts; O

1986
The use of nonradiolabelled steroid infusions to investigate the origin of oestrone sulphate in postmenopausal women.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1986, Volume: 18, Issue:11

    Topics: Androstenediols; Androstenedione; Estrone; Female; Humans; Infusions, Parenteral; Menopause; Metabol

1986
Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:4

    Topics: Bone Diseases, Metabolic; Calcifediol; Calcitriol; Estradiol; Estrone; Female; Humans; Longitudinal

1987
Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:11

    Topics: Aged; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Me

1986
[Serum hormone level and Kupperman menopausal complaints in sexually mature women with disturbance of ovulation].
    Nihon Sanka Fujinka Gakkai zasshi, 1985, Volume: 37, Issue:1

    Topics: Adult; Amenorrhea; Climacteric; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotrop

1985
The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
    Maturitas, 1985, Volume: 7, Issue:2

    Topics: Adult; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Ho

1985
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
    Maturitas, 1985, Volume: 7, Issue:2

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Hu

1985
Early menopausal changes in bone mass and sex steroids.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 61, Issue:5

    Topics: Adult; Androstenedione; Bone and Bones; Calcium; Calcium-Binding Proteins; Estradiol; Estrone; Fasti

1985
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
    Gynecologic oncology, 1986, Volume: 23, Issue:1

    Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti

1986
Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:3

    Topics: Aged; Androstenedione; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Midd

1986
The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause.
    British journal of obstetrics and gynaecology, 1985, Volume: 92, Issue:3

    Topics: Age Factors; Aged; Androstenedione; Body Composition; Body Height; Body Weight; Estradiol; Estrogens

1985
Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.
    Cancer research, 1985, Volume: 45, Issue:6

    Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Cell Nucleus; Cytosol; Estradiol; Estrogens; Estr

1985
Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics.
    Metabolism: clinical and experimental, 1985, Volume: 34, Issue:6

    Topics: Aged; Bone and Bones; Diabetes Mellitus; Diabetes Mellitus, Type 2; Estrone; Female; Gonadal Steroid

1985
Oestrone sulphate, adipose tissue, and breast cancer.
    Breast cancer research and treatment, 1985, Volume: 6, Issue:1

    Topics: Adipose Tissue; Animals; Breast; Breast Neoplasms; Cattle; Estrone; Female; Fibrocystic Breast Disea

1985
Hormone metabolism: body weight and extraglandular estrogen production.
    Clinical obstetrics and gynecology, 1985, Volume: 28, Issue:3

    Topics: Adrenalectomy; Androstenedione; Anorexia Nervosa; Aromatase; Body Weight; Estrogens; Estrone; Female

1985
Plasma oestrogens and oestrogen receptors in breast cancer patients.
    British journal of cancer, 1985, Volume: 52, Issue:5

    Topics: Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Receptors, Estrogen

1985
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone.
    Clinical endocrinology, 1985, Volume: 23, Issue:4

    Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neo

1985
Endocrine profiles and breast cancer.
    Lancet (London, England), 1973, Jan-27, Volume: 1, Issue:7796

    Topics: 11-Hydroxycorticosteroids; Adult; Aged; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estriol

1973
[Excretion of estrogens and testosterone following administration of dehydroepiandrosterone sulfate].
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:12

    Topics: Administration, Oral; Adult; Dehydroepiandrosterone; Estradiol; Estriol; Estrogens; Estrone; Female;

1970
Post-menopausal hyperoestrogenism caused by carcinoma of the adrenal cortex.
    Acta obstetricia et gynecologica Scandinavica, 1970, Volume: 49, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Aged; Carcinoma; Dehydroepiandr

1970
Studies on the urinary excretion, biological effects and origin of oestrogens in post-menopausal women.
    Acta endocrinologica, 1968, Volume: 60 Suppl 135

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Age Factors

1968
Evaluation of equilin 3-monosulfate and other estrogens. Comparison by study of urinary gonadotropins in women.
    Archives of internal medicine, 1971, Volume: 128, Issue:2

    Topics: 17-Ketosteroids; Administration, Oral; Adult; Aged; Amenorrhea; Animals; Biological Assay; Castratio

1971
Piperazine estrone sulfate and conjugated estrogens equine in the treatment of the menopausal syndrome.
    Southern medical journal, 1971, Volume: 64, Issue:9

    Topics: Adult; Aged; Anxiety; Blushing; Depression; Estrogens, Conjugated (USP); Estrone; Female; Genital Di

1971
A technique for the assay of 17-hydroxyprogesterone (17-hydroxy-4-pregnene-3,20-dione) in serum using celite column chromatography and competitive protein binding.
    Steroids, 1971, Volume: 18, Issue:2

    Topics: 17-Ketosteroids; Acetates; Acylation; Alcohols; Androstanes; Anhydrides; Chemical Phenomena; Chemist

1971
Carcinoma of the breast during estrogen replacement therapy.
    Cancer, 1972, Volume: 29, Issue:3

    Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating;

1972
Oestrogen metabolism in cultured human breast tumours.
    British journal of cancer, 1972, Volume: 26, Issue:6

    Topics: Adenocarcinoma, Scirrhous; Adenofibroma; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninf

1972
Adrenal and testicular contribution to plasma oestrogens.
    The Journal of endocrinology, 1972, Volume: 55, Issue:1

    Topics: 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Androstanes; Breast Neopl

1972
[Separation of the sulfate and glucuronate fractions of urinary steriods: a new analytical method (author's transl)].
    Clinica chimica acta; international journal of clinical chemistry, 1974, Mar-26, Volume: 51, Issue:3

    Topics: Adult; Androsterone; Chromatography, Thin Layer; Estradiol; Estrogens, Conjugated (USP); Estrone; Ev

1974
Mass fragmentographic determination of eleven estrogens in the body fluids of pregnant and nonpregnant subjects.
    Journal of steroid biochemistry, 1974, Volume: 5, Issue:3

    Topics: 17-Ketosteroids; Aluminum; Bile; Chromatography; Chromatography, Gas; Estradiol; Estriol; Estrogens;

1974
[Excretion of classic estrogens and total phenol steroids in patients with cancer of the uterine cervix].
    Voprosy onkologii, 1974, Volume: 20, Issue:9

    Topics: Adult; Cell Nucleus; Chromatography, Thin Layer; Cobalt Radioisotopes; Estradiol; Estriol; Estrogens

1974
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.
    The Journal of clinical endocrinology and metabolism, 1974, Volume: 39, Issue:6

    Topics: Adult; Aged; Androstenedione; Arm; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans;

1974
Comparison of quick methods of the estimation of estradiol in plasma by radioimmunoassay.
    Journal of steroid biochemistry, 1974, Volume: 5, Issue:5

    Topics: Adult; Cross Reactions; Estradiol; Estrone; Evaluation Studies as Topic; Female; Fertility; Humans;

1974
The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia.
    Gynecologic oncology, 1974, Volume: 2, Issue:2-3

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Androstenedione; Endometrium; Estrone; Female; Humans; Men

1974
[The effect of synthetic estrogens (mestranol, estrone cyanate and quinestrol) on carbohydrate and lipid metabolism during menopause].
    Das Deutsche Gesundheitswesen, 1974, Nov-04, Volume: 29, Issue:47

    Topics: Cyanates; Estradiol Congeners; Estrone; Fatty Acids, Nonesterified; Female; Glucose; Glucose Toleran

1974
Estimation of "total-oestrogens". Evaluation of a fluorimetric method.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1974, Volume: 29

    Topics: Adult; Aged; Animals; Biological Assay; Chromatography; Estradiol; Estriol; Estrogens; Estrone; Eval

1974
Therapy of the menopause with esterified estrogens standardized with sodium estrone sulphate.
    Current therapeutic research, clinical and experimental, 1972, Volume: 14, Issue:1

    Topics: Aged; Esters; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Sulfates; Time Factors

1972
[Influence of the oral adminsitration of estrogens on serum gonadotropins and prolactin after the menopause].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1972, Volume: 1, Issue:5 Suppl 2

    Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Mi

1972
Source of estrogen production in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:2

    Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female

1973
Source of estrogen production in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:2

    Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female

1973
Source of estrogen production in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:2

    Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female

1973
Source of estrogen production in postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:2

    Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female

1973
Estrogen metabolism in patients at high risk for endometrial carcinoma. II. The role of androstenedione as an estrogen precursor in postmenopausal women with endometrial carcinoma.
    American journal of obstetrics and gynecology, 1973, Aug-01, Volume: 116, Issue:7

    Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Carbon Isotopes; Endometrium; Estriol; Estrogens;

1973
Plasma estrogens in postmenopausal women.
    American journal of obstetrics and gynecology, 1973, Aug-15, Volume: 116, Issue:8

    Topics: Adult; Age Factors; Aged; Body Weight; Castration; Diabetes Mellitus; Endometrial Hyperplasia; Endom

1973
Radioimmunoassay of serum estrogen.
    Clinical chemistry, 1973, Volume: 19, Issue:7

    Topics: Animals; Binding Sites, Antibody; Charcoal; Chromatography, Gel; Dextrans; Estradiol; Estrogens; Est

1973
Urinary oestrogens in normal Egyptian subjects and in patients with bilharzial hepatosplenomegaly.
    Acta medica Academiae Scientiarum Hungaricae, 1973, Volume: 30, Issue:1

    Topics: Adult; Biopsy; Egypt; Estradiol; Estriol; Estrogens; Estrone; Female; Hepatomegaly; Humans; Liver; L

1973
[Proceedings: Etiology of corpus carcinoma].
    Archiv fur Gynakologie, 1973, Sep-28, Volume: 214, Issue:1

    Topics: Adipose Tissue; Androstenedione; Diabetes Complications; Estradiol; Estrone; Female; Humans; Hyperte

1973
Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women.
    American journal of obstetrics and gynecology, 1974, Jan-15, Volume: 118, Issue:2

    Topics: Adenocarcinoma; Age Factors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hyperp

1974
An improved assay for plasma oestradiol using competitive protein binding.
    Clinica chimica acta; international journal of clinical chemistry, 1974, Jan-19, Volume: 50, Issue:1

    Topics: Adult; Animals; Binding Sites; Chromatography, Affinity; Climacteric; Estradiol; Estrone; Evaluation

1974
Postmenopausal bleeding.
    Journal of the American Geriatrics Society, 1974, Volume: 22, Issue:8

    Topics: Adenocarcinoma; Adrenal Glands; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Me

1974
[Study of the plasma and urinary steroids in the course of treatment of anovulation by human urinary gonadotropins. Presence of estradiol in increased quantities in peripheral vein in the blood in period of follicular maturation].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1968, Jan-22, Volume: 266, Issue:4

    Topics: Amenorrhea; Chromatography, Ion Exchange; Desoxycorticosterone; Estradiol; Estrogens; Estrone; Femal

1968
Urinary estrogen production rates in normal and endocrine-ablated subjects.
    The Journal of clinical endocrinology and metabolism, 1972, Volume: 35, Issue:4

    Topics: 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adult; Age Factors; Androstanes; Carbon Isotopes; Ca

1972
Genetic predisposition to carcinoma of the breast: multiple human genotypes for estrogen 16 alpha hydroxylase activity in Caucasians.
    Journal of surgical oncology, 1972, Volume: 4, Issue:3

    Topics: Breast Diseases; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Genital Neoplasms, Female; G

1972
Gas-liquid chromatographic quantitation of urinary estrogens in nonpregnant women, postmenopausal women, and men.
    American journal of obstetrics and gynecology, 1971, Oct-01, Volume: 111, Issue:3

    Topics: Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Estradiol; Estriol; E

1971
[Estrogen excretion in the female castrate].
    Archiv fur Gynakologie, 1971, Jun-04, Volume: 211, Issue:1

    Topics: Age Factors; Castration; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Ovary

1971
Evaluation of gas-liquid chromatographic techniques for the estimation of oestrogens.
    Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 34, Issue:2

    Topics: Amniotic Fluid; Blood; Castration; Chemistry, Clinical; Chromatography, Gas; Colorimetry; Estradiol;

1971
Metabolic clearance and blood production rates of estrogens in postmenopausal women.
    American journal of obstetrics and gynecology, 1971, Volume: 111, Issue:6

    Topics: Age Factors; Carbon Isotopes; Estradiol; Estrone; Female; Menopause; Metabolic Clearance Rate; Triti

1971
Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma.
    American journal of obstetrics and gynecology, 1969, Dec-15, Volume: 105, Issue:8

    Topics: Chromatography; Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Tr

1969
Studies on the influence of age on oestrogens in post-menopausal women with atrophic endometrium and normal liver function.
    Acta endocrinologica, 1969, Volume: 62, Issue:3

    Topics: Age Factors; Aged; Aging; Atrophy; Castration; Endometrium; Estradiol; Estriol; Estrogens; Estrone;

1969
Estimation of estrone and estradiol in low level urines using electron-capture gas-liquid chromatography.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 31, Issue:4

    Topics: 17-Ketosteroids; Adult; Androstanes; Carbon Isotopes; Child, Preschool; Chromatography, Gas; Chromat

1970
The effect of natural sex steroids on the excretion of follicle-stimulating and luteinizing hormone in postmenopausal women.
    Acta endocrinologica, 1970, Volume: 64, Issue:3

    Topics: Animals; Biological Assay; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone; Gonada

1970
[Urinary excretion of estrogens in women with bleeding during climacteric and in menopause].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1970, Volume: 25, Issue:39

    Topics: Aged; Climacteric; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menarche; Menopause; Mens

1970
Relationship between hormonal cytology and steroid excretion in post-menopausal women.
    The Journal of endocrinology, 1970, Volume: 48, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Aged; Androsterone; Breast Neoplasms; Estriol; Estrogens

1970
[Aacifemine compared with Equigyne in the therapy of menopause disorders].
    Bulletin de la Societe royale belge de gynecologie et d'obstetrique, 1969, Volume: 39, Issue:2

    Topics: Estradiol; Estriol; Estrone; Female; Genital Diseases, Female; Humans; Menopause; Middle Aged

1969
Urinary excretion of oestrogens and the oestrogenic effect in vaginal smears in post-menopausal women with uterine bleeding.
    Acta obstetricia et gynecologica Scandinavica, 1970, Volume: 49, Issue:3

    Topics: Curettage; Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Metrorrhagia; Middle

1970
Studies on the human metabolism of 6:7 3 H oestradiol.
    Steroidologia, 1970, Volume: 1, Issue:3

    Topics: Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Male;

1970
Recent studies on the estimation of human pituitary gonadotrophins in urine in clinical conditions.
    Hormones, 1970, Volume: 1, Issue:2

    Topics: Adult; Aged; Animals; Ascorbic Acid; Climacteric; Clomiphene; Contraceptives, Oral; Estradiol; Estri

1970
The ovarian response in women to large single injections of human menopausal gonadotrophin and human chorionic gonadotrophin.
    Journal of reproduction and fertility, 1970, Volume: 23, Issue:2

    Topics: Adult; Biopsy; Chorionic Gonadotropin; Corpus Luteum; Estradiol; Estriol; Estrone; Female; Gonadotro

1970
Oestrogenic function in postmenopausal women.
    Journal of reproduction and fertility, 1971, Volume: 24, Issue:1

    Topics: Age Factors; Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Fluorometry; Humans; Menopause; M

1971
Endocrinological studies in women approaching the menopause.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1971, Volume: 78, Issue:1

    Topics: Adult; Age Factors; Estradiol; Estriol; Estrogens; Estrone; Feedback; Female; Follicle Stimulating H

1971
A gaschromatographic method for the measurement of small amounts of estrogens in urine.
    Steroids, 1968, Volume: 11, Issue:3

    Topics: Aged; Alkylation; Carbon Isotopes; Chromatography, Gas; Chromatography, Thin Layer; Estradiol; Estri

1968
Hypothalamopituitary hyperactivity and endometrial carcinoma. Qualitative and quantitative disturbances in hormone production.
    American journal of obstetrics and gynecology, 1968, Nov-15, Volume: 102, Issue:6

    Topics: Cholesterol; Chromatography, Thin Layer; Endometrium; Estradiol; Estriol; Estrogens; Estrone; Fatty

1968
[The urinary excretion of estrogens in patients with far advanced breast cancer during treatment with prednisolone].
    Voprosy onkologii, 1968, Volume: 14, Issue:12

    Topics: Adrenal Glands; Breast Neoplasms; Castration; Chromatography; Estradiol; Estriol; Estrogens; Estrone

1968
Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer.
    European journal of cancer, 1968, Volume: 4, Issue:5

    Topics: Aging; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle A

1968
Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Castration; Circadian Rhythm; Estradiol; Estrogens; Estrone; Fema

1969
The climacteric and some of its problems.
    Geriatrics, 1969, Volume: 24, Issue:5

    Topics: Adolescent; Adrenal Glands; Adult; Arteriosclerosis; Climacteric; Coronary Disease; Diethylstilbestr

1969
Endocrine function in postmenopausal women.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1969, Volume: 76, Issue:4

    Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Luteinizing Hormone; Menopause; Middle Aged

1969
A study of estrogen metabolic clearance rates and transfer factors.
    The Journal of clinical investigation, 1969, Volume: 48, Issue:10

    Topics: Adult; Estradiol; Estrogens; Estrone; Female; Glucocorticoids; Humans; Kinetics; Male; Menopause; Me

1969
[On the endocrine substrate of diffuse female (androgenetic) alopecia].
    Archiv fur klinische und experimentelle Dermatologie, 1966, Volume: 227, Issue:1

    Topics: Adult; Aged; Alopecia; Androgens; Estradiol; Estriol; Estrone; Female; Gonadotropins; Humans; Lynest

1966
[Correlation between total gonadotropin excretion and estrogen levels in the urine in the climacteric].
    Quaderni di clinica ostetrica e ginecologica, 1966, Volume: 21, Issue:12

    Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Gonadotropins; Humans; Menopause; Middle Aged

1966